Numerous clinical trials evaluate therapeutic interventions across conditions including lung cancer, cervical cancer, knee osteoarthritis, intraabdominal infections, amyloidosis, and pediatric solid tumors. Spanning Early Phase 1 through Phase 4, these protocols maintain recruitment statuses encompassing completed, recruiting, active, enrolling by invitation, and terminated. The trials are sponsored by commercial entities such as Eisai Inc. and Axsome Therapeutics, as well as cooperative research institutions including the Children's Oncology Group and the Alliance for Clinical Trials in Oncology.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07220187 | NOT_YET_RECRUITING | Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma; Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma |
SWOG Cancer Research Network |
2026-08-31 | PHASE3 |
| NCT07574099 | ACTIVE_NOT_RECRUITING | Maxilla; Tooth Loss / Rehabilitation |
University of Belgrade |
2019-03-01 | |
| NCT04446962 | ACTIVE_NOT_RECRUITING | Lymphoma, Large B-Cell, Diffuse; Central Nervous System Neoplasms, Primary |
Institut Curie |
2020-10-30 | PHASE1; PHASE2 |
| NCT05947851 | RECRUITING | Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Chronic Lymphocytic; Small-Cell Lymphoma; Lymphoma, Small Lymphocytic; CLL; SLL |
Merck Sharp & Dohme LLC |
2023-08-08 | PHASE3 |
| NCT05561387 | RECRUITING | Plasma Cell Myeloma |
SWOG Cancer Research Network |
2023-10-12 | PHASE3 |
| NCT05605899 | ACTIVE_NOT_RECRUITING | High-risk Large B-cell Lymphoma (LBCL) |
Kite, A Gilead Company |
2023-02-10 | PHASE3 |
| NCT07712588 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL) |
Dizal Pharmaceuticals |
2026-09 | PHASE2; PHASE3 |
| NCT07555145 | NOT_YET_RECRUITING | Mental Health; Substance Use Disorders; Co-occurring Mental and Substance Use Disorders |
University of Massachusetts, Worcester |
2026-08-01 | |
| NCT07446660 | RECRUITING | Oncology |
University Health Network, Toronto |
2026-03-23 | |
| NCT07732803 | RECRUITING | Orthopaedic Trauma |
Prince of Wales Hospital, Shatin, Hong Kong |
2026-06-15 | |
| NCT07345741 | NOT_YET_RECRUITING | R/R B-NHL; Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL) |
Donghua Zhang |
2025-12-31 | |
| NCT07162480 | RECRUITING | Adenoid Cystic Carcinoma |
M.D. Anderson Cancer Center |
2026-04-29 | PHASE2 |
| NCT06542250 | RECRUITING | B-cell Malignancies |
AstraZeneca |
2024-09-18 | PHASE1; PHASE2 |
| NCT06880601 | NOT_YET_RECRUITING | Multiple Myleoma; Multiple Myeloma in Relapse; Multiple Myeloma Refractory |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2025-11-01 | PHASE2 |
| NCT06607549 | RECRUITING | Central Nervous System Lymphoma |
University of Utah |
2025-03-18 | PHASE1 |
| NCT07342478 | RECRUITING | CLL / SLL; CLL (Chronic Lymphocytic Leukemia); CLL, Refractory; CLL, Relapsed; SLL (Small Lymphocytic Lymphoma); SLL; CLL; CLL Progression |
Newave Pharmaceutical Inc |
2026-04-23 | PHASE3 |
| NCT07365306 | RECRUITING | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Primary Mediastinal Large B-Cell Lymphoma; Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified; Refractory Primary Mediastinal Large B-Cell Lymphoma; Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma |
City of Hope Medical Center |
2026-07-27 | PHASE2 |
| NCT07706166 | NOT_YET_RECRUITING | Kidney Transplant; Liver Transplant |
University of Wisconsin, Madison |
2026-09 | PHASE4 |
| NCT07468071 | RECRUITING | Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer; Advanced Solid Tumors Harboring the KRAS G12C Mutation |
Novartis Pharmaceuticals |
2026-06-08 | PHASE1; PHASE2 |
| NCT06474455 | RECRUITING | Advanced Solid Tumors |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
2024-07-02 | PHASE1; PHASE2 |
| NCT04694586 | SUSPENDED | Tuberculosis, Pulmonary |
University Hospital, Linkoeping |
2022-11-30 | PHASE2 |
| NCT06812715 | RECRUITING | Chronic Lymphocytic Leukemia |
Peter MacCallum Cancer Centre, Australia |
2025-05-05 | PHASE2 |
| NCT04602468 | ACTIVE_NOT_RECRUITING | Cystic Fibrosis; Cystic Fibrosis Liver Disease; Cystic Fibrosis in Children; Adherence, Medication; Cystic Fibrosis Gastrointestinal Disease |
Royal College of Surgeons, Ireland |
2020-09-03 | PHASE4 |
| NCT04960579 | ACTIVE_NOT_RECRUITING | Multiple Myeloma |
Poseida Therapeutics, Inc. |
2022-05-05 | PHASE1 |
| NCT06970639 | RECRUITING | NSCLC Patients With Brain Metastasis |
Allist Pharmaceuticals, Inc. |
2024-09-26 | PHASE3 |
| NCT06922604 | SUSPENDED | Primary Central Nervous System Lymphoma; Secondary Central Nervous System Lymphoma |
City of Hope Medical Center |
2025-07-30 | PHASE1 |
| NCT07139873 | RECRUITING | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
Dizal Pharmaceuticals |
2025-09-08 | PHASE3 |
| NCT04373564 | RECRUITING | Motor Function; Cognitive Function; Contrast Media |
Guerbet |
2021-03-24 | PHASE4 |
| NCT04092283 | ACTIVE_NOT_RECRUITING | Recurrent Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Unresectable Lung Non-Small Cell Carcinoma |
National Cancer Institute (NCI) |
2020-04-29 | PHASE3 |
| NCT06634589 | RECRUITING | B-cell Malignancy; Relapsed Cancer; Refractory Cancer; B-cell Lymphoma |
BeOne Medicines |
2024-11-27 | PHASE1; PHASE2 |
| NCT02657785 | RECRUITING | Primary Central Nervous System Lymphoma |
Navy General Hospital, Beijing |
2010-09 | PHASE2; PHASE3 |
| NCT07636694 | RECRUITING | Depression - Major Depressive Disorder |
The University of Hong Kong |
2025-02-24 | |
| NCT01993810 | ACTIVE_NOT_RECRUITING | Stage II Non-Small Cell Lung Cancer AJCC v7; Stage IIA Non-Small Cell Lung Carcinoma AJCC v7; Stage IIB Non-Small Cell Lung Carcinoma AJCC v7; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7 |
Radiation Therapy Oncology Group |
2014-01-03 | PHASE3 |
| NCT07185373 | RECRUITING | Primary Central Nervous System Lymphoma |
Huashan Hospital |
2025-10-01 | PHASE2; PHASE3 |
| NCT07588698 | NOT_YET_RECRUITING | Non-Hodgkin's B-cell Lymphoma; Lymphoma Non-Hodgkin; Diffuse Large B-Cell Lymphoma (DLBCL) |
Carrie Ho, MD |
2026-09-15 | PHASE2 |
| NCT07397832 | RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL) |
Tianjin Medical University Cancer Institute and Hospital |
2026-02-03 | PHASE2 |
| NCT07661095 | RECRUITING | Acute Myeloid Leukemia; AML; Refractory Acute Myeloid Leukemia |
Memorial Sloan Kettering Cancer Center |
2026-06-15 | PHASE1 |
| NCT02156739 | ACTIVE_NOT_RECRUITING | Hepatocellular Carcinoma; Liver and Intrahepatic Bile Duct Disorder; Metastatic Malignant Neoplasm in the Liver; Primary Malignant Liver Neoplasm |
M.D. Anderson Cancer Center |
2014-10-13 | |
| NCT07018752 | RECRUITING | Peripheral T Cells Lymphoma (PTCL) |
The Lymphoma Academic Research Organisation |
2025-08-20 | PHASE1; PHASE2 |
| NCT07538635 | RECRUITING | High-risk R/R LBCL |
Zhejiang Cancer Hospital |
2026-04-20 | PHASE2 |
| NCT07538180 | ACTIVE_NOT_RECRUITING | Newly Diagnosed MYC/BCL2 Double-expressor DLBCL |
Sun Yat-sen University |
2025-10-30 | PHASE2 |
| NCT07617285 | RECRUITING | AML; Refractory/Relapse Acute Myeloid Leukemia |
Peking University People's Hospital |
2026-05-07 | PHASE1 |
| NCT07539740 | RECRUITING | Disorders of Consciousness; Vegetative State; Minimally Conscious State |
Zhujiang Hospital |
2026-03-08 | |
| NCT05253495 | RECRUITING | Non-hodgkin Lymphoma; Hodgkin Lymphoma |
New York Medical College |
2022-02-01 | PHASE2 |
| NCT06956001 | RECRUITING | EGFR; NSCLC (Advanced Non-small Cell Lung Cancer) |
Allist Pharmaceuticals, Inc. |
2024-11-19 | PHASE3 |
| NCT07418749 | RECRUITING | Recurrent Cervical Cancer; Metastatic Cervical Cancer |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2026-03-30 | PHASE3 |
| NCT04521231 | ACTIVE_NOT_RECRUITING | B Cell Precursor Acute Lymphoblastic Leukemia |
Amgen |
2021-01-04 | PHASE1; PHASE2 |
| NCT06660368 | RECRUITING | Relapsed or Refractory Acute Myeloid Leukemia (AML) |
H. Lee Moffitt Cancer Center and Research Institute |
2024-11-26 | PHASE2 |
| NCT01696734 | RECRUITING | Digestive System Disorder; Dyspepsia; Esophagitis; Gastroesophageal Reflux Disease; Gastroparesis; Heartburn; Nausea and Vomiting |
M.D. Anderson Cancer Center |
2012-10-23 | PHASE3 |
| NCT07451652 | RECRUITING | Relapsed/Refractory Diffuse Large B Cell Lymphoma |
Hospital Universitario Dr. Jose E. Gonzalez |
2026-03-17 | PHASE2 |
| NCT07321301 | RECRUITING | B-cell Lymphoma Refractory |
Daihong Liu |
2025-09-01 | PHASE2 |
| NCT03919240 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia With Failed Remission |
The First Affiliated Hospital of Soochow University |
2015-12-01 | PHASE1; PHASE2 |
| NCT07735585 | RECRUITING | Alcohol Use Disorder (AUD) |
University of Sao Paulo General Hospital |
2026-02-19 | |
| NCT05370430 | RECRUITING | Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma |
PeproMene Bio, Inc. |
2022-06-13 | PHASE1 |
| NCT07024147 | NOT_YET_RECRUITING | B-Cell Non-Hodgkin Lymphoma; Large B Cell Diffuse Lymphoma; Follicular Lymphoma; Marginal Zone B Cell Lymphoma; Mantle Cell Lymphoma (MCL) |
Peking University Cancer Hospital & Institute |
2025-07-01 | PHASE1 |
| NCT05862012 | RECRUITING | Relapsed/Refractory Multiple Myeloma |
Ichnos Sciences SA |
2023-11-01 | PHASE1 |
| NCT03821935 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors Cancer |
AbbVie |
2019-02-21 | PHASE1 |
| NCT06937320 | ENROLLING_BY_INVITATION | Heart Failure With Preserved Ejection Fraction (HFPEF); Heart Failure With Normal Ejection Fraction; Heart Failure, Diastolic |
Duke University |
2025-07-28 | PHASE2 |
| NCT06514027 | RECRUITING | Non Small Cell Lung Cancer |
BeBetter Med Inc |
2024-08-28 | PHASE2 |
| NCT06475300 | RECRUITING | Non-small Cell Lung Cancer; Nasopharyngeal Carcinoma; Solid Tumor |
Sichuan Baili Pharmaceutical Co., Ltd. |
2024-06-25 | PHASE2 |
| NCT07546409 | RECRUITING | Prediabetes; Healthy (Controls) |
University of Alabama at Birmingham |
2025-05-20 | |
| NCT04002947 | RECRUITING | Non-Hodgkin's Lymphoma; Diffuse Large B-Cell Lymphoma; DLBCL; NHL |
National Cancer Institute (NCI) |
2019-08-05 | PHASE2 |
| NCT06251999 | NOT_YET_RECRUITING | Elderly Patients |
Shanghai 6th People's Hospital |
2024-08-01 | PHASE4 |
| NCT03630991 | RECRUITING | Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Risk Myelodysplastic Syndrome; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Myelodysplastic Syndrome; Recurrent Myelodysplastic/Myeloproliferative Neoplasm; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Myelodysplastic Syndrome; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndrome; Very High Risk Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2018-10-11 | PHASE1 |
| NCT06667687 | ACTIVE_NOT_RECRUITING | Non-Hodgkin's Lymphoma |
AbbVie |
2025-01-16 | PHASE1 |
| NCT05428969 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Relapsed/Refractory AML |
Faron Pharmaceuticals Ltd |
2022-06-02 | PHASE1; PHASE2 |
| NCT04267848 | RECRUITING | Lung Non-Small Cell Carcinoma; Lung Non-Small Cell Squamous Carcinoma; Lung Non-Squamous Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8 |
National Cancer Institute (NCI) |
2020-06-16 | PHASE3 |
| NCT07369492 | RECRUITING | B-cell Lymphoma |
Jiangsu Topcel-KH Pharmaceutical Co., Ltd. |
2026-01-01 | PHASE1 |
| NCT05988632 | RECRUITING | Alcohol Use Disorder |
Brown University |
2025-02-25 | PHASE1; PHASE2 |
| NCT06874946 | RECRUITING | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T - Cell Lymphoma; PTCL |
Peking University People's Hospital |
2025-02-14 | PHASE1; PHASE2 |
| NCT07333508 | NOT_YET_RECRUITING | Lower Extremity Surgery |
Ya-Qun Zhou |
2026-01-01 | PHASE4 |
| NCT07788157 | NOT_YET_RECRUITING | Endoscopic Sinus Surgery; Total Intravenous Anesthesia; Fospropofol Disodium |
Tongji Hospital |
2026-08-01 | |
| NCT06266715 | RECRUITING | Depression |
Nanfang Hospital, Southern Medical University |
2024-03-04 | |
| NCT06783647 | RECRUITING | Advanced Solid Tumour |
Nanjing Leads Biolabs Co.,Ltd |
2025-06-11 | PHASE2 |
| NCT06750991 | NOT_YET_RECRUITING | DLBCL |
Ruijin Hospital |
2024-12-31 | PHASE2 |
| NCT07036406 | RECRUITING | Aphasia; Aphasia Following Cerebral Infarction; Aphasia, Acquired; Aphasia, Rehabilitation; Aphasia, Anomic; Aphasia, Broca; Aphasia, Conduction; Aphasia, Expressive; Aphasia Non Fluent; Aphasia, Mixed |
Teachers College, Columbia University |
2025-07-28 | PHASE2 |
| NCT03982693 | ACTIVE_NOT_RECRUITING | Critical Limb Ischemia; Diabetes |
Mt. Sinai Medical Center, Miami |
2019-03-19 | PHASE3 |
| NCT06104592 | RECRUITING | Large B-cell Lymphoma; Relapsed Non-Hodgkin Lymphoma |
H. Lee Moffitt Cancer Center and Research Institute |
2023-11-08 | PHASE2 |
| NCT07236762 | RECRUITING | Systemic Lupus Erythematosus; Lupus Nephritis (LN); Sjogren's Syndrome; Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
2025-11-24 | PHASE1 |
| NCT05585411 | RECRUITING | Bradyarrhythmia; Atrioventricular Block; Left Bundle Branch Area Pacing |
Yonsei University |
2022-11-01 | |
| NCT06674265 | RECRUITING | Neuroblastoma, Recurrent, Refractory; Neuroblastoma (NB); Neuroblastoma in Children |
Marzieh Ebrahimi |
2024-11-10 | PHASE1 |
| NCT06977711 | RECRUITING | Diffuse Large B-cell Lymphoma |
The University of Texas Health Science Center at San Antonio |
2025-06-20 | PHASE1 |
| NCT06622694 | RECRUITING | Severe Aplastic Anemia; Relapse; Refractory; CAR T-cell Therapy |
Institute of Hematology & Blood Diseases Hospital, China |
2025-06-19 | PHASE1 |
| NCT02194738 | ACTIVE_NOT_RECRUITING | Stage IB Lung Non-Small Cell Carcinoma AJCC v7; Stage II Lung Non-Small Cell Cancer AJCC v7; Stage IIA Lung Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Cancer AJCC v8 |
National Cancer Institute (NCI) |
2014-09-26 | |
| NCT07659132 | NOT_YET_RECRUITING | Anesthesia for Urologic Endoscopic Surgery; Urinary Calculi |
Shiyou Wei |
2026-06-26 | PHASE4 |
| NCT07636746 | ACTIVE_NOT_RECRUITING | Morbid Obesity |
Ain Shams University |
2026-04-17 | |
| NCT07183176 | NOT_YET_RECRUITING | Acute Back Pain; Emergency Department Patient |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2025-09-15 | |
| NCT03467386 | SUSPENDED | Acute Myeloid Leukemia |
City of Hope Medical Center |
2018-03-19 | PHASE1 |
| NCT07675200 | RECRUITING | Autophagy; Healthy Aging |
Nutraland USA, Inc. |
2026-01-09 | |
| NCT06092671 | RECRUITING | Postoperative Complications; Child; Family; Emergence Delirium; General Anaesthesia; Perioperative Care |
Second Affiliated Hospital of Wenzhou Medical University |
2023-10-24 | |
| NCT06138782 | ACTIVE_NOT_RECRUITING | Anorexia Nervosa |
University of California, San Francisco |
2023-10-16 | |
| NCT04913103 | NOT_YET_RECRUITING | Lymphoma, Mantle-Cell |
Czech Lymphoma Study Group |
2021-09-01 | PHASE2 |
| NCT07104721 | RECRUITING | Systemic Lupus Erythematosus (SLE); Lupus Nephritis (LN); Systemic Sclerosis (SSc); Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome (APS) |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
2025-08-04 | PHASE1 |
| NCT07348575 | ENROLLING_BY_INVITATION | Lymphoma, Large-Cell, Diffuse |
Second Affiliated Hospital of Nanchang University |
2024-07-01 | PHASE3 |
| NCT05345197 | ACTIVE_NOT_RECRUITING | Acquired Hemophilia A |
University of Washington |
2022-08-31 | PHASE2 |
| NCT06738251 | RECRUITING | Advanced Urothelial Carcinoma |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
2025-02-12 | PHASE3 |
| NCT07412015 | NOT_YET_RECRUITING | T2DM (Type 2 Diabetes Mellitus) |
Chipscreen Biosciences, Ltd. |
2026-05-27 | |
| NCT06501196 | RECRUITING | Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Preleukemia; Myelodysplastic Syndromes; Refractory Acute Myeloid Leukemia |
BlossomHill Therapeutics |
2024-06-19 | PHASE1 |
| NCT05870917 | ACTIVE_NOT_RECRUITING | Plasma Cell Leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
2023-05-23 | PHASE2 |
| NCT05956457 | RECRUITING | Multiple Myeloma; Relapsed Hematologic Malignancy |
Pack Health |
2023-09-15 | |
| NCT07233889 | RECRUITING | Hypophosphatemia |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
2025-11-21 | |
| NCT04898543 | ACTIVE_NOT_RECRUITING | Metastatic Solid Tumor |
ImmunityBio, Inc. |
2021-06-21 | PHASE1 |
| NCT05934097 | WITHDRAWN | Diffuse Large B Cell Lymphoma; Transformed Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma |
Fate Therapeutics |
2022-12 | PHASE1 |
| NCT06493071 | UNKNOWN | Spinal Cord Injury; Depression |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2025-01-27 | |
| NCT05453500 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
University of Washington |
2023-03-27 | PHASE2 |
| NCT07406217 | RECRUITING | COVID-19; Immunodeficiency |
Calmy Alexandra |
2023-04-27 | PHASE2 |
| NCT06939166 | RECRUITING | Neuromyelitis Optica Spectrum Disorders; Myasthenia Gravis; Multiple Sclerosis; Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Autoimmune Encephalitis |
Tianjin Huanhu Hospital |
2025-06-17 | EARLY_PHASE1 |
| NCT06980233 | ACTIVE_NOT_RECRUITING | Substance Use Disorder (SUD); Mental Health Disorder; Criminal Recidivism |
Meaningful Measurement, Inc |
2025-06-01 | |
| NCT06199921 | RECRUITING | Pulmonary Tuberculosis; Tuberculosis; Koch's Disease |
Obafemi Awolowo University Teaching Hospital |
2024-01-03 | PHASE2 |
| NCT05866393 | COMPLETED | Pathogen Transmission; Patient Participation; Aging |
Case Western Reserve University |
2023-08-17 | |
| NCT07368569 | COMPLETED | Healthy |
Boehringer Ingelheim |
2026-02-06 | PHASE1 |
| NCT05743270 | WITHDRAWN | Squamous Cell Carcinoma of Head and Neck; Locally Advanced Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma |
Replimune, Inc. |
2024-01-30 | PHASE2 |
| NCT07342062 | COMPLETED | Healthy |
Dong-A ST Co., Ltd. |
2026-01-06 | PHASE1 |
| NCT06835842 | RECRUITING | Pneumonia |
Cairo University |
2025-03-10 | |
| NCT07569614 | COMPLETED | Postoperative Delirium (POD); Thoracoscopic Surgery; Dexmedetomidine; Remimazolam Besylate |
First Affiliated Hospital of Kunming Medical University |
2025-04-01 | |
| NCT06732427 | COMPLETED | Efficacy and Safety |
Affiliated Hospital of Nantong University |
2025-08-12 | |
| NCT04947319 | ACTIVE_NOT_RECRUITING | Refractory Primary Central Nervous System Lymphoma; Primary CNS Lymphoma |
Ono Pharmaceutical Co., Ltd. |
2021-12-29 | PHASE2 |
| NCT06201247 | RECRUITING | Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory |
Peking University People's Hospital |
2023-12-30 | EARLY_PHASE1 |
| NCT04332822 | RECRUITING | DLBCL; Diffuse Large B Cell Lymphoma |
Nordic Lymphoma Group |
2020-08-19 | PHASE3 |
| NCT03602157 | ACTIVE_NOT_RECRUITING | Lymphoma; Immune System Diseases; Immunoproliferative Disorders; Lymphatic Diseases; Lymphoproliferative Disorders; Neoplasms; Cutaneous Lymphoma; Cutaneous Anaplastic Large Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Lymphomatoid Papulosis; Cutaneous T Cell Lymphoma; Gray Zone Lymphoma |
UNC Lineberger Comprehensive Cancer Center |
2018-10-29 | PHASE1 |
| NCT06385678 | ACTIVE_NOT_RECRUITING | Advanced KRAS G12D Mutant Solid Tumors |
Jiangsu HengRui Medicine Co., Ltd. |
2024-07-05 | PHASE1; PHASE2 |
| NCT07092384 | COMPLETED | Remifentanil; Adverse Effects |
Tongji Hospital |
2025-07-30 | |
| NCT06126354 | WITHDRAWN | Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity |
Columbia University |
2024-07-01 | PHASE1 |
| NCT06659042 | RECRUITING | Lung Cancer, Non-Small Cell |
Shanghai Chest Hospital |
2024-11-20 | PHASE2 |
| NCT06200467 | COMPLETED | Overweight; Obesity |
Boehringer Ingelheim |
2024-03-13 | PHASE1 |
| NCT06511895 | COMPLETED | Peripheral T Cell Lymphoma |
Dizal Pharmaceuticals |
2022-05-31 | PHASE2 |
| NCT05754853 | RECRUITING | Advanced or Metastatic Urothelium Cancer |
Shanghai Miracogen Inc. |
2023-04-06 | PHASE3 |
| NCT04920565 | RECRUITING | Multiple Organ Dysfunction With Severe Endotoxemia |
Petrovsky National Research Centre of Surgery |
2021-11-01 | |
| NCT06026566 | UNKNOWN | Remimazolam; Awake Endotracheal Intubation |
Tongji Hospital |
2023-04-01 | |
| NCT04895735 | ACTIVE_NOT_RECRUITING | Metastatic Salivary Gland Carcinoma; Recurrent Salivary Gland Carcinoma; Stage IV Major Salivary Gland Cancer AJCC v8; Adenoid Cystic Carcinoma |
Mayo Clinic |
2021-07-23 | PHASE2 |
| NCT06844266 | NOT_YET_RECRUITING | Asthma in Children |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
2025-03-01 | |
| NCT06561035 | UNKNOWN | Anterior Cruciate Ligament Injuries |
Campbell Clinic |
2024-09-01 | PHASE3 |
| NCT05422066 | UNKNOWN | DLBCL Germinal Center B-Cell Type |
Li Zhiming |
2022-07-26 | PHASE2 |
| NCT06027957 | COMPLETED | B-Cell Non Hodgkin Lymphoma; B-Cell Acute Lymphoblastic Leukemia |
Vinmec Research Institute of Stem Cell and Gene Technology |
2023-08-02 | PHASE1 |
| NCT06633055 | NOT_YET_RECRUITING | Healthy Subjects (HS) |
Biotech Pharmaceutical Co., Ltd. |
2024-10-31 | PHASE1 |
| NCT05051891 | COMPLETED | Treatment-naїve Mantle Cell Lymphoma |
Beijing InnoCare Pharma Tech Co., Ltd. |
2021-12-22 | PHASE3 |
| NCT06418074 | COMPLETED | Ketosis; Essential Hypertension |
Gødstrup Hospital |
2024-09-11 | |
| NCT05348213 | RECRUITING | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2022-05-16 | PHASE2 |
| NCT06434662 | UNKNOWN | Relapsed/Refractory Acute Myeloid Leukaemia; Myeloid Malignancy |
First Affiliated Hospital of Zhejiang University |
2024-02-29 | PHASE2 |
| NCT03111173 | RECRUITING | Fetal Monitoring |
University of Washington |
2017-06-02 | |
| NCT05667506 | RECRUITING | B-cell Acute Lymphoblastic Leukemia |
Juventas Cell Therapy Ltd. |
2023-02-07 | PHASE1; PHASE2 |
| NCT05904171 | COMPLETED | Parkinson Disease |
Istituto Auxologico Italiano |
2023-02-20 | |
| NCT04973007 | TERMINATED | Oligometastatic Disease; Liver Metastases; Colorectal Cancer |
University of Colorado, Denver |
2021-06-22 | PHASE4 |
| NCT05744440 | UNKNOWN | Acute Myeloid Leukemia |
Xuzhou Medical University |
2023-03-01 | EARLY_PHASE1 |
| NCT05889585 | RECRUITING | Germ Cell Tumor |
Gustave Roussy, Cancer Campus, Grand Paris |
2023-05-31 | |
| NCT06743997 | COMPLETED | Healthy Volunteers |
LG Chem |
2025-01-13 | PHASE1 |
| NCT06103318 | UNKNOWN | Breast Cancer; Cognitive Dysfunction |
Institut Català d'Oncologia |
2024-03-14 | |
| NCT05201248 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Genmab |
2022-03-10 | PHASE1; PHASE2 |
| NCT06895759 | COMPLETED | Avalanche Burial |
Institute of Mountain Emergency Medicine |
2025-03-20 | |
| NCT06813469 | ACTIVE_NOT_RECRUITING | Ring 14 |
IRCCS Azienda Ospedaliero-Universitaria di Bologna |
2023-12-15 | |
| NCT05894395 | UNKNOWN | Mumps; Measles; Rubella |
University of Zurich |
2023-12-01 | PHASE3 |
| NCT05668962 | RECRUITING | Thyroid Cancer; Thyroid Carcinoma; Metastatic Thyroid Cancer; Follicular Thyroid Cancer; Unresectable Thyroid Gland Carcinoma; Papillary Thyroid Cancer |
Massachusetts General Hospital |
2023-03-01 | PHASE2 |
| NCT06344325 | COMPLETED | Elective Surgery |
Tongji Hospital |
2024-05-01 | PHASE4 |
| NCT03895658 | WITHDRAWN | Unipolar Depression |
National Institute of Mental Health (NIMH) |
2025-02-26 | PHASE1 |
| NCT06270732 | UNKNOWN | Emotional Intelligence; Social Interaction; Mental Health Wellness 1; Well-Being, Psychological |
Universitat Autonoma de Barcelona |
2024-02-05 | |
| NCT06009965 | UNKNOWN | Aplastic Anemia; CSA; Drug Therapy |
Peking Union Medical College Hospital |
2023-01-20 | PHASE4 |
| NCT05987696 | COMPLETED | AML, Adult; Minimal Residual Disease |
Institute of Hematology & Blood Diseases Hospital, China |
2023-07-31 | PHASE1 |
| NCT06153082 | UNKNOWN | Liver Cirrhosis |
Institute of Liver and Biliary Sciences, India |
2023-12-16 | |
| NCT04432714 | RECRUITING | DLBCL; Untreated; MYC Gene Rearrangement |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-09 | PHASE1; PHASE2 |
| NCT06569485 | RECRUITING | DLBCL |
Sun Yat-sen University |
2024-05-23 | PHASE2 |
| NCT05132413 | UNKNOWN | Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2021-12-30 | PHASE3 |
| NCT06224842 | UNKNOWN | Angioimmunoblastic T-cell Lymphoma |
Huijing Wu |
2023-12-12 | PHASE1; PHASE2 |
| NCT05333302 | UNKNOWN | B-cell Acute Lymphoblastic Leukemia; Lymphoblastic B-Cell Lymphoma |
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology |
2020-10-26 | PHASE1 |
| NCT05583149 | ACTIVE_NOT_RECRUITING | Refractory Aggressive B-cell Lymphomas; Refractory B-Cell Non-Hodgkin Lymphoma; Aggressive B-cell NHL; Diffuse Large B-cell Lymphoma (DLBCL); De Novo or Transformed Indolent B-cell Lymphoma; DLBCL, Nos Genetic Subtypes; T Cell/Histiocyte-rich Large B-cell Lymphoma; EBV-Positive DLBCL, Nos; Primary Mediastinal [Thymic] Large B-cell Lymphoma (PMBCL); High-Grade B-Cell Lymphoma, Nos; C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma; Grade 3b Follicular Lymphoma; C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma |
Patrick C. Johnson, MD |
2023-03-01 | PHASE2 |
| NCT05596097 | UNKNOWN | Diffuse Large B-cell Lymphoma (DLBCL) |
LanZhou University |
2022-10-30 | PHASE2 |
| NCT03220022 | ACTIVE_NOT_RECRUITING | AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2018-03-16 | PHASE1 |
| NCT05930951 | TERMINATED | Adenoid Cystic Carcinoma of the Head and Neck |
Groupe Oncologie Radiotherapie Tete et Cou |
2023-11-29 | PHASE1 |
| NCT06828874 | COMPLETED | Intraabdominal Infections |
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd |
2023-05-10 | PHASE4 |
| NCT05923541 | COMPLETED | Hematologic Malignancies |
Henan Cancer Hospital |
2023-06-26 | EARLY_PHASE1 |
| NCT05473221 | UNKNOWN | AML |
Zhejiang University |
2022-08-02 | PHASE1 |
| NCT03530683 | TERMINATED | Lymphoma; Multiple Myeloma; Acute Myeloid Leukemia; Diffuse Large B-Cell Lymphoma |
Pfizer |
2018-05-14 | PHASE1 |
| NCT05222555 | ACTIVE_NOT_RECRUITING | Diffuse Large B Cell Lymphoma |
Incyte Corporation |
2022-07-19 | PHASE1; PHASE2 |
| NCT06046898 | COMPLETED | Acute Respiratory Failure |
University Hospital, Angers |
2023-11-06 | |
| NCT03493139 | COMPLETED | Physical Activity |
University of Kansas Medical Center |
2018-03-01 | |
| NCT02927769 | COMPLETED | Hodgkin Disease |
Bristol-Myers Squibb |
2017-03-28 | PHASE2 |
| NCT06107270 | UNKNOWN | Deep Neck Flexors Training; Post Isometric Relaxation |
Cairo University |
2023-11-01 | |
| NCT05613036 | COMPLETED | Solid Tumors |
Boehringer Ingelheim |
2023-01-03 | PHASE1 |
| NCT07033182 | COMPLETED | Infections Caused by Anaerobic Bacteria; Renal Impairment |
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd |
2023-10-30 | PHASE1 |
| NCT04138927 | ENROLLING_BY_INVITATION | Warm Antibody Autoimmune Hemolytic Anemia |
Rigel Pharmaceuticals |
2019-10-30 | PHASE3 |
| NCT05786989 | UNKNOWN | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified |
Chongqing University Cancer Hospital |
2023-02-28 | PHASE4 |
| NCT05559008 | UNKNOWN | Peripheral T Cell Lymphoma |
Ruijin Hospital |
2022-09-30 | PHASE1; PHASE2 |
| NCT04450836 | TERMINATED | Metastatic Colorectal Cancer |
UNICANCER |
2020-11-23 | PHASE2 |
| NCT06193811 | COMPLETED | Healthy |
Boehringer Ingelheim |
2024-01-16 | PHASE1 |
| NCT04256889 | COMPLETED | Prematurity; Extreme Prematurity |
Woman's |
2020-01-15 | |
| NCT05870514 | UNKNOWN | Critical Illness |
Xiaobo Yang, MD |
2023-06-01 | PHASE2 |
| NCT06126523 | UNKNOWN | Stroke; Spasticity as Sequela of Stroke |
Saglik Bilimleri Universitesi |
2023-12-01 | |
| NCT06446466 | COMPLETED | PEMF Effect |
University of Bologna |
2023-11-12 | |
| NCT06806423 | COMPLETED | Immediate Dental Implant; Implant Osseointegration; Vitamin D; Tooth Extraction |
Suez Canal University |
2022-10-11 | |
| NCT05438394 | UNKNOWN | Multiple Myeloma |
Peking University People's Hospital |
2022-10-13 | PHASE1 |
| NCT04214626 | COMPLETED | Diffuse Large B Cell Lymphoma |
Henan Cancer Hospital |
2020-01-05 | PHASE2 |
| NCT03797456 | COMPLETED | MZL |
Beijing InnoCare Pharma Tech Co., Ltd. |
2019-04-01 | PHASE2 |
| NCT06130527 | UNKNOWN | Other Complications of Surgical and Medical Procedures |
Erol Karaaslan |
2023-11-30 | |
| NCT03137771 | ACTIVE_NOT_RECRUITING | Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer |
NRG Oncology |
2017-04-07 | PHASE2 |
| NCT05346952 | UNKNOWN | Advanced Non-squamous Non-small Cell Lung Cancer |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2022-01-25 | PHASE3 |
| NCT06116240 | UNKNOWN | Solid Tumor |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2022-09-02 | PHASE1 |
| NCT03415061 | UNKNOWN | Delirium; Heart Diseases |
Hiroaki Sato, MD., PhD. |
2021-11-01 | |
| NCT04840121 | COMPLETED | Fertility |
Clinique Ovo |
2021-03-24 | |
| NCT04158141 | TERMINATED | Pleural Biphasic Mesothelioma; Pleural Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v8; Stage IA Pleural Malignant Mesothelioma AJCC v8; Stage IB Pleural Malignant Mesothelioma AJCC v8; Stage II Pleural Malignant Mesothelioma AJCC v8; Stage IIIA Pleural Malignant Mesothelioma AJCC v8 |
NRG Oncology |
2020-01-29 | PHASE3 |
| NCT05661279 | UNKNOWN | Postoperative Pain |
Zagazig University |
2022-12-30 | |
| NCT01413100 | COMPLETED | Systemic Scleroderma |
Fred Hutchinson Cancer Center |
2011-09-15 | PHASE2 |
| NCT06201559 | COMPLETED | Intestinal Diseases |
GlaxoSmithKline |
2023-08-21 | PHASE1 |
| NCT04061590 | WITHDRAWN | Lung Non-Small Cell Carcinoma; Stage I Lung Cancer AJCC v8; Stage IA1 Lung Cancer AJCC v8; Stage IA2 Lung Cancer AJCC v8; Stage IA3 Lung Cancer AJCC v8; Stage IB Lung Cancer AJCC v8; Stage II Lung Cancer AJCC v8; Stage IIA Lung Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8 |
University of California, San Francisco |
2020-05-29 | PHASE2 |
| NCT04379635 | ACTIVE_NOT_RECRUITING | Non Small Cell Lung Cancer |
BeiGene |
2020-05-29 | PHASE3 |
| NCT05767827 | COMPLETED | Local Anesthesia Adjuvants; Upper Extremity Fracture; Brachial Plexus Block |
Nepal Medical College and Teaching Hospital |
2023-02-01 | |
| NCT04785807 | UNKNOWN | Covid19; Post Traumatic Stress Disorder; Anxiety |
Hospices Civils de Lyon |
2021-03-30 | |
| NCT03569696 | UNKNOWN | Lymphoma, B-Cell |
Meirav Kedmi MD |
2018-10-08 | PHASE2 |
| NCT02733185 | COMPLETED | Diabetes; Myocardial Infarction |
Mt. Sinai Medical Center, Miami |
2016-10-01 | PHASE3 |
| NCT07393581 | COMPLETED | Anxiety; Emotional Well-Being; Social Connectedness |
Chinese University of Hong Kong |
2023-05-02 | |
| NCT05491278 | COMPLETED | Critical Illness |
Xiaobo Yang, MD |
2022-08-10 | PHASE2 |
| NCT05668715 | UNKNOWN | Urinary Bladder, Overactive |
Pamukkale University |
2023-01-01 | |
| NCT05478343 | UNKNOWN | Multiple Myeloma |
Beijing Immunochina Medical Science & Technology Co., Ltd. |
2021-05-06 | EARLY_PHASE1 |
| NCT03941496 | WITHDRAWN | Tuberculosis, Pulmonary |
Andrew Dinardo |
2022-10 | PHASE1; PHASE2 |
| NCT05124353 | UNKNOWN | Stroke, Acute, Ischemic |
Pomeranian Medical University Szczecin |
2021-04-27 | PHASE2; PHASE3 |
| NCT03682536 | ACTIVE_NOT_RECRUITING | Myelodysplastic Syndromes |
Celgene |
2019-01-02 | PHASE3 |
| NCT04626752 | UNKNOWN | Relapsed or Refractory Multiple Myeloma |
Hebei Senlang Biotechnology Inc., Ltd. |
2020-04-01 | EARLY_PHASE1 |
| NCT05622370 | UNKNOWN | Partial Seizure |
Overseas Pharmaceuticals, Ltd. |
2022-09-13 | PHASE1 |
| NCT04842318 | UNKNOWN | Follicular Lymphoma |
Ruijin Hospital |
2021-03-01 | PHASE4 |
| NCT04854330 | UNKNOWN | Type 2 Diabetes |
University of Portsmouth |
2021-04-26 | |
| NCT03310619 | COMPLETED | Lymphoma, Non-Hodgkin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular |
Celgene |
2017-12-20 | PHASE1; PHASE2 |
| NCT02960646 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Aplastic Anemia; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Lymphoblastic Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Therapy-Related Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2017-01-18 | PHASE1 |
| NCT06255080 | COMPLETED | Simulation Training; Laparoscopy |
Copenhagen Academy for Medical Education and Simulation |
2022-09-01 | |
| NCT02535312 | ACTIVE_NOT_RECRUITING | Advanced Malignant Solid Neoplasm; Advanced Peritoneal Malignant Mesothelioma; Advanced Pleural Malignant Mesothelioma; Recurrent Peritoneal Malignant Mesothelioma; Recurrent Pleural Malignant Mesothelioma; Refractory Malignant Solid Neoplasm; Unresectable Solid Neoplasm |
National Cancer Institute (NCI) |
2016-03-08 | PHASE1; PHASE2 |
| NCT05315778 | UNKNOWN | ITP |
The First Affiliated Hospital of Soochow University |
2022-01-01 | PHASE2 |
| NCT04432402 | UNKNOWN | Diffuse Large B Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-14 | |
| NCT07040826 | COMPLETED | Dry Eye Syndromes |
Qilu Pharmaceutical Co., Ltd. |
2022-12-06 | PHASE1 |
| NCT05474040 | COMPLETED | Analgesia Post Craniotomy |
Zagazig University |
2021-12-15 | |
| NCT05683951 | COMPLETED | Respiratory Infection |
Daewon Pharmaceutical Co., Ltd. |
2021-11-26 | PHASE3 |
| NCT00986661 | UNKNOWN | Cancer Metastatic to the Liver; Hepatocellular Carcinoma; Metastatic Melanoma; Metastatic Ocular Melanoma; Metastatic Uveal Melanoma; Metastatic Lung Cancer; Metastatic Colon Cancer; Metastatic Colorectal Cancer; Metastatic Breast Cancer; Metastatic Pancreatic Cancer |
Provectus Biopharmaceuticals, Inc. |
2009-10 | PHASE1 |
| NCT05518357 | COMPLETED | Relapsed/Refractory Acute Myeloid Leukemia |
Hebei Yanda Ludaopei Hospital |
2022-06-24 | PHASE1 |
| NCT03520218 | COMPLETED | Breast Cancer |
University Health Network, Toronto |
2019-12-17 | |
| NCT02636322 | COMPLETED | Diffuse Large B-Cell Lymphoma Unclassifiable |
M.D. Anderson Cancer Center |
2016-03-29 | PHASE2 |
| NCT05467839 | COMPLETED | Vitiligo |
Sohag University |
2022-07-31 | |
| NCT03228537 | ACTIVE_NOT_RECRUITING | Biphasic Mesothelioma; Epithelioid Mesothelioma; Stage I Pleural Diffuse Malignant Mesothelioma AJCC v7; Stage IA Pleural Diffuse Malignant Mesothelioma AJCC v7; Stage IB Pleural Diffuse Malignant Mesothelioma AJCC v7; Stage II Pleural Diffuse Malignant Mesothelioma AJCC v7; Stage III Pleural Diffuse Malignant Mesothelioma AJCC v7 |
National Cancer Institute (NCI) |
2018-07-16 | PHASE1 |
| NCT03898843 | TERMINATED | Anxiety; Mood Disorders; Post Traumatic Stress Disorder |
Hospices Civils de Lyon |
2020-09-18 | |
| NCT04236011 | UNKNOWN | Multiple Myeloma |
Shanghai Changzheng Hospital |
2020-01-16 | EARLY_PHASE1 |
| NCT04248868 | COMPLETED | Pulmonary Embolism |
Thrombolex, Inc. |
2020-06-23 | PHASE3 |
| NCT03133195 | COMPLETED | Unstable Intertrochanteric Fracture; Pertrochanteric Fracture of Femur, Closed |
King Chulalongkorn Memorial Hospital |
2017-05-17 | PHASE3 |
| NCT03437356 | COMPLETED | Atrial Fibrillation |
AZ Sint-Jan AV |
2018-02-26 | |
| NCT05249374 | COMPLETED | Hepatic Ascites |
Beijing Protgen Biotechnology Development Co., Ltd. |
2021-10-14 | PHASE1 |
| NCT04822597 | COMPLETED | Breast Cancer; Sentinel Lymph Node; Breast Neoplasms; Breast Cancer Female |
University of Wisconsin, Madison |
2021-04-23 | PHASE3 |
| NCT03483987 | TERMINATED | Chronic Hepatitis C |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2018-02-10 | |
| NCT05339373 | COMPLETED | Bioequivalence |
Pharmtechnology LLC |
2022-04-15 | PHASE1 |
| NCT04873063 | COMPLETED | Healthy Adult Male Volunteers |
SOFAR S.p.A. |
2021-10-22 | PHASE1 |
| NCT05062785 | COMPLETED | Out-Of-Hospital Cardiac Arrest; Healthy |
Robert Silbergleit |
2021-10-04 | PHASE1 |
| NCT05100589 | COMPLETED | Cognitive Change; Mood |
University of Central Florida |
2021-10-06 | |
| NCT03971474 | COMPLETED | Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8 |
SWOG Cancer Research Network |
2019-05-28 | PHASE2 |
| NCT04312360 | COMPLETED | Right-sided Colon Cancer; Right-sided Colon Adenoma |
Zealand University Hospital |
2020-01-16 | PHASE2 |
| NCT03764618 | COMPLETED | Warm Antibody Autoimmune Hemolytic Anemia |
Rigel Pharmaceuticals |
2019-04-24 | PHASE3 |
| NCT04203485 | UNKNOWN | PD-L1 Positive Non-small Cell Lung Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2020-06-15 | PHASE3 |
| NCT02871297 | TERMINATED | Depressive Disorder, Major |
H. Lundbeck A/S |
2016-08-17 | PHASE3 |
| NCT04878315 | WITHDRAWN | Healthy Volunteers |
GlaxoSmithKline |
2022-02-13 | PHASE1 |
| NCT05083559 | COMPLETED | Type 1 Diabetes |
Oregon Health and Science University |
2021-12-08 | |
| NCT02120365 | COMPLETED | Alcoholism |
Virginia Commonwealth University |
2019-06-01 | PHASE1; PHASE2 |
| NCT03066154 | TERMINATED | Prostatic Neoplasms |
The Netherlands Cancer Institute |
2016-09 | PHASE1 |
| NCT03740958 | COMPLETED | Stroke |
General Hospital of Shenyang Military Region |
2018-12-21 | PHASE4 |
| NCT04948502 | COMPLETED | Pulmonary Embolism |
ShenZhen KYD Biomedical Technology Co., Ltd. |
2020-08-13 | |
| NCT04063033 | COMPLETED | Heart Failure |
Rambam Health Care Campus |
2019-09-01 | PHASE4 |
| NCT06258174 | COMPLETED | Healthy |
Eli Lilly and Company |
2021-09-28 | PHASE1 |
| NCT00796068 | COMPLETED | Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Myelodysplastic Syndrome (MDS) |
Fred Hutchinson Cancer Center |
2009-02-24 | PHASE2 |
| NCT05108350 | UNKNOWN | Type II Diabetes |
Shandong Suncadia Medicine Co., Ltd. |
2021-11-09 | PHASE1 |
| NCT06100757 | COMPLETED | Pacing-Induced Cardiomyopathy |
Universitaire Ziekenhuizen KU Leuven |
2018-05-01 | |
| NCT02628405 | UNKNOWN | Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma |
Academic and Community Cancer Research United |
2016-05-20 | PHASE1; PHASE2 |
| NCT02693067 | UNKNOWN | Neuroendocrine Tumors Metastatic to the Liver |
Provectus Biopharmaceuticals, Inc. |
2016-07 | PHASE1 |
| NCT05189002 | UNKNOWN | Venous Thromboembolism |
PharmaDiall Ltd. |
2019-05-31 | PHASE2 |
| NCT03631576 | UNKNOWN | Relapsed/Refractory AML |
Fujian Medical University |
2018-08-10 | PHASE2; PHASE3 |
| NCT01030900 | COMPLETED | Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2009-10-22 | PHASE2 |
| NCT05311982 | COMPLETED | Autistic Disorders Spectrum |
Federal University of Paraíba |
2021-03-01 | |
| NCT04619251 | COMPLETED | Healthy |
Boehringer Ingelheim |
2020-11-13 | PHASE1 |
| NCT04592822 | UNKNOWN | Anticoagulant |
Hong Kong WD Pharmaceutical Co., Limited |
2021-01-06 | PHASE1 |
| NCT05235230 | COMPLETED | Bioequivalence |
Future University in Egypt |
2021-05-19 | PHASE1 |
| NCT04228445 | COMPLETED | Ureter Injury |
Prove pharm |
2020-02-13 | PHASE3 |
| NCT04439890 | UNKNOWN | Advanced Non-squamous Cell Non-small Cell Lung Cancer |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2019-08-08 | PHASE3 |
| NCT04004637 | UNKNOWN | T-lymphoblastic Lymphoma; NK/T Cell Lymphoma; Acute Lymphocytic Leukemia |
PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
2019-08-25 | PHASE1 |
| NCT04082975 | COMPLETED | Acute Low Back Pain |
NVP Healthcare |
2020-01-15 | PHASE3 |
| NCT01833559 | UNKNOWN | Gestational Diabetes |
First Affiliated Hospital, Sun Yat-Sen University |
2012-06 | |
| NCT04830579 | UNKNOWN | Bioequivalence |
Pharmtechnology LLC |
2021-04-10 | PHASE1 |
| NCT04623996 | TERMINATED | Anemia in Myelodysplastic Syndromes |
Sumitomo Pharma America, Inc. |
2020-12-28 | PHASE1; PHASE2 |
| NCT04441671 | WITHDRAWN | Pseudoxanthoma Elasticum |
Tampere University Hospital |
2020-12-08 | PHASE2 |
| NCT04714437 | COMPLETED | Chewing Problem; Mastication Disorder |
University of Barcelona |
2021-02-08 | |
| NCT04194645 | COMPLETED | Healthy |
Boehringer Ingelheim |
2020-01-09 | PHASE1 |
| NCT03391466 | COMPLETED | Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
Kite, A Gilead Company |
2018-01-25 | PHASE3 |
| NCT05039502 | COMPLETED | Inflammatory Response; Root Canal Infection |
Bulent Ecevit University |
2020-10-01 | |
| NCT03112642 | TERMINATED | Other Biomechanical Lesions of Upper Extremity |
Rutgers, The State University of New Jersey |
2013-11 | |
| NCT04642859 | COMPLETED | Dyslexia |
Assiut University |
2020-11-14 | |
| NCT03879824 | TERMINATED | Aortic Stenosis; Aortic Valve Disease; Vascular Access Complication |
Carilion Clinic |
2019-05-30 | |
| NCT02564744 | COMPLETED | Diffuse Large B-Cell Lymphoma; B-cell Non-Hodgkin's Lymphoma |
Debiopharm International SA |
2016-06-05 | PHASE2 |
| NCT03910673 | COMPLETED | Bacterial Infection; Multiple-drug Resistance; Pathogen Resistance |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-06-27 | PHASE1 |
| NCT03366766 | TERMINATED | Non-Squamous Non-Small Cell Lung Carcinoma; Stage I Non-Small Cell Lung Cancer; Stage IA Non-Small Cell Lung Carcinoma; Stage IB Non-Small Cell Lung Carcinoma; Stage II Non-Small Cell Lung Cancer; Stage IIA Non-Small Cell Lung Carcinoma; Stage IIB Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2017-12-20 | PHASE2 |
| NCT02746068 | UNKNOWN | Osteoarthritis, Knee |
Axsome Therapeutics, Inc. |
2016-03 | PHASE3 |
| NCT02522429 | TERMINATED | Consciousness Disorders; Brain Injuries |
University of California, Los Angeles |
2016-03-10 | |
| NCT04028518 | UNKNOWN | Acute Ischemic Stroke |
Angde Biotech Pharmaceutical Co., Ltd. |
2019-07-20 | PHASE2 |
| NCT04250298 | COMPLETED | Iron-deficiency |
Medical University of Graz |
2019-11-13 | |
| NCT04243434 | UNKNOWN | Hematologic Diseases |
Acrotech Biopharma Inc. |
2020-08-15 | PHASE1 |
| NCT02942277 | COMPLETED | Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-10-21 | PHASE1 |
| NCT05330000 | COMPLETED | Healthy Adults |
The Affiliated Hospital of Qingdao University |
2020-05-22 | PHASE1 |
| NCT02408016 | TERMINATED | Advanced Pleural Malignant Mesothelioma; HLA-A*0201 Positive Cells Present; Recurrent Non-Small Cell Lung Carcinoma; Recurrent Pleural Malignant Mesothelioma; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage III Pleural Malignant Mesothelioma AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IV Non-Small Cell Lung Cancer AJCC v7; Stage IV Pleural Malignant Mesothelioma AJCC v7; WT1 Positive |
Fred Hutchinson Cancer Center |
2015-05-22 | PHASE1; PHASE2 |
| NCT06876623 | COMPLETED | Bioequivalence of Dabigatran Etexilate Mesylate Capsules From Two Different Manufacturers in Healthy Chinese Subjects |
The Affiliated Hospital Of Guizhou Medical University |
2019-12-10 | PHASE1 |
| NCT02077192 | COMPLETED | Immune Thrombocytopenic Purpura |
Rigel Pharmaceuticals |
2014-10 | PHASE3 |
| NCT03242447 | COMPLETED | Teen Pregnancy Prevention |
The Policy & Research Group |
2017-08-02 | |
| NCT04028960 | TERMINATED | Type1diabetes |
HealthPartners Institute |
2019-10-23 | PHASE2 |
| NCT03990389 | COMPLETED | Depression, Postpartum; Depression, Unipolar |
University of Chicago |
2019-02-20 | |
| NCT02535325 | COMPLETED | Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma; Stage III Lung Adenocarcinoma AJCC v7; Stage III Lung Large Cell Carcinoma AJCC v7; Stage III Lung Non-Small Cell Cancer AJCC v7; Stage IIIA Lung Adenocarcinoma AJCC v7; Stage IIIA Lung Large Cell Carcinoma AJCC v7; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Adenocarcinoma AJCC v7; Stage IIIB Lung Large Cell Carcinoma AJCC v7; Stage IIIB Lung Non-Small Cell Cancer AJCC v7; Stage IV Lung Adenocarcinoma AJCC v7; Stage IV Lung Large Cell Carcinoma AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7 |
National Cancer Institute (NCI) |
2015-09-30 | PHASE1 |
| NCT02641691 | COMPLETED | Cancer of Rectum; Cancer of the Rectum; Neoplasm, Rectum; Rectal Cancer; Rectum Cancer; Rectum Neoplasms; Adenocarcinoma of the Rectum |
Washington University School of Medicine |
2016-05-27 | PHASE2 |
| NCT05084456 | WITHDRAWN | Solid Tumor, Adult; Impaired Liver Function |
Modra Pharmaceuticals |
2017-07 | PHASE1 |
| NCT05038423 | COMPLETED | Leadership; Identification; Empowerment |
KU Leuven |
2018-03-01 | |
| NCT04184414 | UNKNOWN | B Acute Lymphoblastic Leukemia; Mantle Cell Lymphoma; Follicular Lymphoma |
PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
2018-01-09 | EARLY_PHASE1 |
| NCT02693717 | TERMINATED | Metastatic Urothelial Carcinoma |
M.D. Anderson Cancer Center |
2017-05-09 | PHASE2 |
| NCT04212208 | UNKNOWN | Pain, Procedural |
All India Institute of Medical Sciences, Rishikesh |
2019-02-01 | |
| NCT01700569 | TERMINATED | Grade IV Astrocytoma; Glioblastoma |
Institut Cancerologie de l'Ouest |
2013-01 | PHASE1 |
| NCT02858804 | COMPLETED | Mantle Cell Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2016-01 | PHASE4 |
| NCT02612558 | COMPLETED | Warm Antibody Autoimmune Hemolytic Anemia |
Rigel Pharmaceuticals |
2016-07 | PHASE2 |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT03294551 | COMPLETED | Vaccines |
University of California, Los Angeles |
2017-10-27 | |
| NCT03351842 | RECRUITING | Chemotherapy, Adjuvant; Lung Adenocarcinoma, Stage I; Treatment; Histological Type of Neoplasm |
Shanghai Pulmonary Hospital, Shanghai, China |
2017-09-01 | PHASE2 |
| NCT00392327 | COMPLETED | Anaplastic Medulloblastoma; Medulloblastoma |
Children's Oncology Group |
2007-05-23 | PHASE3 |
| NCT03525795 | COMPLETED | Advanced Solid Tumors |
Constellation Pharmaceuticals |
2017-12-14 | PHASE1 |
| NCT03756415 | UNKNOWN | Acute Hypercapnic Respiratory Failure |
IRCCS Azienda Ospedaliero-Universitaria di Bologna |
2019-01-01 | |
| NCT02772822 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Sinocelltech Ltd. |
2016-06 | PHASE3 |
| NCT04289714 | COMPLETED | Asthma in Children |
Imperial College London |
2018-10-12 | |
| NCT02150993 | COMPLETED | HIV-2 Infection |
ANRS, Emerging Infectious Diseases |
2016-01-26 | PHASE2; PHASE3 |
| NCT05531994 | COMPLETED | Healthy Volunteers |
Qilu Pharmaceutical Co., Ltd. |
2018-11-27 | |
| NCT04254042 | COMPLETED | Hypertension |
Yaounde Central Hospital |
2018-10-01 | PHASE4 |
| NCT03722186 | SUSPENDED | Physiological Effects of Drugs; Neoplasms by Histologic Type; Lymphoma; Hematologic Neoplasms; Immunotherapy; Advanced Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2018-11-13 | PHASE1 |
| NCT03120208 | COMPLETED | Postpartum Hemorrhage; Postpartum Women; Postpartum Depression; Postpartum Stress; Postpartum Anxiety |
University Hospital, Clermont-Ferrand |
2017-04-27 | |
| NCT02288897 | TERMINATED | Cutaneous Melanoma |
Provectus Biopharmaceuticals, Inc. |
2015-04 | PHASE3 |
| NCT03627078 | COMPLETED | Trauma, Psychological; Post Traumatic Stress Disorder |
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez |
2016-03-01 | |
| NCT03901716 | COMPLETED | Sufentanil; Remifentanil; Fentanyl; Bronchoscopy; Narcotrend; Conscious Sedation |
Guangzhou Institute of Respiratory Disease |
2019-01-15 | PHASE4 |
| NCT03782987 | COMPLETED | Healthy |
Boehringer Ingelheim |
2019-01-10 | PHASE1 |
| NCT03478618 | UNKNOWN | Hypotension Drug-Induced |
Assiut University |
2018-03 | EARLY_PHASE1 |
| NCT03424746 | COMPLETED | Critical Limb Ischemia; Peripheral Arterial Disease |
Mt. Sinai Medical Center, Miami |
2015-08 | EARLY_PHASE1 |
| NCT01107626 | COMPLETED | Lung Cancer |
ECOG-ACRIN Cancer Research Group |
2010-10-25 | PHASE3 |
| NCT05125575 | COMPLETED | Pharmacokinetics |
Joint Stock Company "Farmak" |
2019-01-11 | PHASE1 |
| NCT01664754 | COMPLETED | Stage IV Non-small Cell Lung Cancer |
Jonsson Comprehensive Cancer Center |
2012-09-07 | PHASE1 |
| NCT03169777 | WITHDRAWN | Colorectal Cancer |
ImmunityBio, Inc. |
2018-08 | PHASE1; PHASE2 |
| NCT02772640 | COMPLETED | Hypercholesterolemia |
Collegium Medicum w Bydgoszczy |
2016-03 | PHASE4 |
| NCT03189433 | TERMINATED | Drug Toxicity Psychotropic Agents Psychostimulants |
Eagle Pharmaceuticals, Inc. |
2017-08-12 | PHASE2 |
| NCT01992653 | COMPLETED | Lymphoma, Non Hodgkin |
Genentech, Inc. |
2013-11-29 | PHASE1; PHASE2 |
| NCT02421029 | WITHDRAWN | Heavy Metal Toxicity |
Mt. Sinai Medical Center, Miami |
2017-07 | PHASE4 |
| NCT02371161 | UNKNOWN | Non Hodgkin Lymphoma |
Fondazione Italiana Linfomi - ETS |
2014-02 | PHASE2 |
| NCT03892161 | TERMINATED | HIV Infections |
University of Cape Town |
2018-04-12 | PHASE1 |
| NCT02955641 | UNKNOWN | Glaucoma, Closed-Angle; Glaucoma, Narrow-Angle; Glaucoma, Angle-Closure |
Sheba Medical Center |
2016-11-01 | |
| NCT05025696 | COMPLETED | Scabies |
Indonesia University |
2018-09-18 | |
| NCT02748564 | TERMINATED | Metastatic Melanoma; Stage III Mucosal Melanoma of the Head and Neck; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Stage IVA Mucosal Melanoma of the Head and Neck; Stage IVB Mucosal Melanoma of the Head and Neck; Stage IVC Mucosal Melanoma of the Head and Neck |
Rutgers, The State University of New Jersey |
2017-03-21 | PHASE2 |
| NCT02616029 | COMPLETED | HIV-1 Infection |
Gilead Sciences |
2015-12-17 | PHASE3 |
| NCT01784640 | COMPLETED | Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
Jonsson Comprehensive Cancer Center |
2014-01-31 | PHASE1 |
| NCT00943800 | COMPLETED | Leukemia; Myelodysplastic Syndrome; Multiple Myeloma; Lymphoma |
University of Chicago |
2006-10-09 | |
| NCT03239873 | COMPLETED | Varicella |
Merck Sharp & Dohme LLC |
2017-10-17 | PHASE3 |
| NCT03037203 | COMPLETED | Excessive Sleepiness; Parkinson Disease |
Jazz Pharmaceuticals |
2017-01 | PHASE2 |
| NCT03215355 | WITHDRAWN | Primary Liver Cancer; Metastatic Liver Cancer |
Slawa Cwajna |
2017-08 | PHASE4 |
| NCT03324061 | COMPLETED | Pharmacokinetics |
Eagle Pharmaceuticals, Inc. |
2017-11-30 | PHASE1 |
| NCT01064648 | ACTIVE_NOT_RECRUITING | Epithelioid Mesothelioma; Pleural Malignant Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatoid Mesothelioma |
National Cancer Institute (NCI) |
2010-03-15 | PHASE1; PHASE2 |
| NCT03505151 | COMPLETED | Healthy |
Boehringer Ingelheim |
2018-04-27 | PHASE1 |
| NCT02194998 | TERMINATED | HIV Infections; Hepatitis C |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-09-16 | PHASE2 |
| NCT02426658 | COMPLETED | Stage IV Non-Small Cell Lung Cancer |
Wake Forest University Health Sciences |
2015-05 | PHASE2 |
| NCT02842736 | COMPLETED | Menorrhagia |
Channel Medsystems |
2016-04 | |
| NCT01258855 | COMPLETED | Metastatic Melanoma; Recurrent Melanoma; Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7 |
National Cancer Institute (NCI) |
2011-01-18 | PHASE2 |
| NCT01435018 | COMPLETED | HIV-1 Infection |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2013-10-01 | PHASE3 |
| NCT01971073 | TERMINATED | Schizophrenia |
Bar-Ilan University, Israel |
2015-01 | |
| NCT02209155 | TERMINATED | Episodic Cluster Headache |
Center Laboratories, Inc. |
2013-11 | PHASE2 |
| NCT02626338 | COMPLETED | Relapsed/Refractory Acute Myeloid Leukemia (AML) |
Arog Pharmaceuticals, Inc. |
2016-02 | PHASE1; PHASE2 |
| NCT03392714 | UNKNOWN | PCNSL |
Chonnam National University Hospital |
2016-01-20 | PHASE2 |
| NCT00004088 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
City of Hope Medical Center |
1999-04-13 | PHASE2 |
| NCT02518802 | UNKNOWN | Lung Neoplasms |
Tang-Du Hospital |
2015-01 | PHASE3 |
| NCT02455362 | WITHDRAWN | Chronic Obstructive Pulmonary Disease; Dyspnea |
Flinders University |
2015-05 | PHASE3 |
| NCT00127205 | COMPLETED | Breast Cancer |
SWOG Cancer Research Network |
2005-07 | PHASE3 |
| NCT02785614 | COMPLETED | Depression |
Lee's Pharmaceutical Limited |
2017-05-01 | PHASE1 |
| NCT00950365 | COMPLETED | Bronchioloalveolar Carcinoma; Large Cell Lung Carcinoma; Lung Adenocarcinoma; Recurrent Non-Small Cell Lung Carcinoma; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer |
Albert Einstein College of Medicine |
2006-04 | PHASE2 |
| NCT03050905 | COMPLETED | HCV Coinfection |
HaEmek Medical Center, Israel |
2017-06-22 | PHASE4 |
| NCT03424655 | COMPLETED | Relate Post-endodontic Pain |
Jorge Paredes Vieyra |
2017-11-12 | |
| NCT03235947 | COMPLETED | Urinary Tract Infection; Asymptomatic Bacteriuria |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2016-09-07 | PHASE4 |
| NCT01992978 | UNKNOWN | Hepatocellular Carcinoma; Cirrhosis |
Southwest Hospital, China |
2013-11 | |
| NCT01958372 | COMPLETED | Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; Large Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2014-08 | PHASE1 |
| NCT01482104 | COMPLETED | Skin Neoplasms; Carcinoma, Basal Cell |
Norwegian University of Science and Technology |
2012-06 | |
| NCT04378608 | COMPLETED | Hepatitis C Virus Infection |
Beni-Suef University |
2017-01-05 | PHASE1; PHASE2 |
| NCT02142049 | COMPLETED | Diffuse Large B Cell Lymphoma Relapsed; Diffuse Large B Cell Lymphoma Refractory |
Pharmacyclics LLC. |
2014-05 | PHASE1; PHASE2 |
| NCT03151499 | COMPLETED | Healthy |
Boehringer Ingelheim |
2017-05-30 | PHASE1 |
| NCT01085630 | COMPLETED | Malignant Mesothelioma |
Alliance for Clinical Trials in Oncology |
2010-04 | PHASE2 |
| NCT01481272 | COMPLETED | Diffuse Large B Cell Lymphoma |
Polish Lymphoma Research Group |
2011-11 | PHASE2 |
| NCT02199041 | TERMINATED | Hematological Malignancies |
St. Jude Children's Research Hospital |
2014-07-11 | PHASE2 |
| NCT02219737 | COMPLETED | CD20 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2014-09-12 | PHASE1 |
| NCT03196817 | UNKNOWN | Carpal Tunnel Syndrome |
Hospital Alvorada |
2016-08-01 | PHASE4 |
| NCT01935947 | TERMINATED | Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2013-05 | PHASE2 |
| NCT02403986 | COMPLETED | Aged Skin |
Galderma R&D |
2015-04 | PHASE4 |
| NCT00573989 | TERMINATED | Head and Neck Cancer |
Wake Forest University Health Sciences |
2008-03 | PHASE1; PHASE2 |
| NCT01032603 | COMPLETED | Exotropia |
Jaeb Center for Health Research |
2010-06-01 | |
| NCT02348593 | COMPLETED | Narcolepsy |
Jazz Pharmaceuticals |
2015-05 | PHASE3 |
| NCT02607423 | WITHDRAWN | Stage IIIA Non-Small Cell Lung Cancer |
ECOG-ACRIN Cancer Research Group |
2015-11-19 | PHASE2 |
| NCT02675894 | COMPLETED | HCC; Metastasis |
Seoul National University Hospital |
2014-04-14 | |
| NCT01041781 | TERMINATED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2010-02 | PHASE3 |
| NCT02107222 | WITHDRAWN | COPD; Chronic Obstructive Pulmonary Disease |
Maquet Cardiopulmonary GmbH |
||
| NCT02700022 | TERMINATED | Diffuse Large B-cell Lymphoma; Follicular Lymphoma; Burkitt Lymphoma |
UNC Lineberger Comprehensive Cancer Center |
2016-10 | PHASE1 |
| NCT01193842 | COMPLETED | AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
2010-10-06 | PHASE1; PHASE2 |
| NCT02635243 | WITHDRAWN | Type 1 Diabetes Mellitus |
Sanofi |
2016-04 | PHASE1 |
| NCT02544659 | COMPLETED | SAPHO Syndrome |
Peking Union Medical College Hospital |
2015-10 | PHASE1 |
| NCT02043847 | COMPLETED | Multiple Myeloma, Relapsed; Multiple Myeloma, Refractory to Standard Treatment |
University of Illinois at Chicago |
2014-01-14 | PHASE1 |
| NCT01723800 | COMPLETED | Recurrent Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
City of Hope Medical Center |
2013-07 | PHASE1 |
| NCT02134912 | TERMINATED | Adenocarcinoma of the Lung; Large Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
SWOG Cancer Research Network |
2014-08 | PHASE2 |
| NCT01810159 | COMPLETED | Substance Use Disorders |
RAND |
2014-06 | |
| NCT00390000 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Mayo Clinic |
2007-01-25 | PHASE1 |
| NCT02076412 | COMPLETED | Immune Thrombocytopenic Purpura |
Rigel Pharmaceuticals |
2015-01 | PHASE3 |
| NCT02223364 | COMPLETED | Total Knee Arthroplasty |
Mayo Clinic |
2014-07 | PHASE4 |
| NCT02501863 | COMPLETED | Pain |
National Medical Center, Seoul |
2015-10 | |
| NCT01011218 | COMPLETED | Insomnia; Fatigue |
Stanford University |
2011-01 | PHASE2 |
| NCT02219672 | UNKNOWN | AIDS/HIV PROBLEM |
Peking Union Medical College |
2014-07 | PHASE3 |
| NCT02394691 | COMPLETED | Disorders of Consciousness; Severe Brain Injury; Post-comatose Non-communicative Patients |
University of Liege |
2014-07 | |
| NCT02095951 | COMPLETED | Leukemia; Lymphoma; Blood Disorders; Solid Tumors |
Children's Hospital of Michigan |
2014-06 | PHASE4 |
| NCT01344824 | COMPLETED | Lung Cancer |
UNC Lineberger Comprehensive Cancer Center |
2010-03 | PHASE2 |
| NCT02076399 | COMPLETED | Immune Thrombocytopenic Purpura |
Rigel Pharmaceuticals |
2014-07-14 | PHASE3 |
| NCT02079805 | COMPLETED | Essential Hypertension Complicated by Type 2 Diabetes Mellitus |
Takeda |
2014-06 | PHASE4 |
| NCT00906841 | TERMINATED | B-cell Lymphoma |
French Innovative Leukemia Organisation |
2007-10 | PHASE2 |
| NCT02425241 | COMPLETED | HIV |
University College, London |
2013-10 | PHASE1; PHASE2 |
| NCT01215747 | COMPLETED | Amyloidosis |
C.T. Development America, Inc. |
2010-11 | PHASE3 |
| NCT01450215 | COMPLETED | Multiple Myeloma |
Karolinska University Hospital |
2011-03 | PHASE2 |
| NCT02574845 | COMPLETED | Healthy |
Boehringer Ingelheim |
2015-10-12 | PHASE1 |
| NCT01807962 | TERMINATED | Periarthritis; Bursitis |
Stephane Genevay |
2011-11 | PHASE3 |
| NCT01769170 | COMPLETED | CMV |
Jazz Pharmaceuticals |
2013-08 | PHASE3 |
| NCT02538003 | COMPLETED | Healthy |
LigaChem Biosciences, Inc. |
2015-09 | PHASE1 |
| NCT02399345 | COMPLETED | Chronic Hepatitis C Virus (HCV Infection Genotype 1) |
AbbVie |
2015-03 | PHASE3 |
| NCT02478879 | COMPLETED | Postmenopausal Osteoporosis |
Zosano Pharma Corporation |
2015-06 | PHASE1 |
| NCT01116037 | TERMINATED | Heart Valve Diseases |
Medtronic Cardiovascular |
2009-09 | |
| NCT00324805 | COMPLETED | Stage IB Lung Non-Small Cell Carcinoma AJCC v7; Stage IIA Lung Non-Small Cell Carcinoma AJCC v7; Stage IIB Lung Non-Small Cell Carcinoma AJCC v7; Stage IIIA Lung Non-Small Cell Cancer AJCC v7 |
National Cancer Institute (NCI) |
2007-07-19 | PHASE3 |
| NCT02452879 | UNKNOWN | Overactive Bladder |
Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
2014-10 | |
| NCT02345447 | COMPLETED | Acute Otitis Media |
University Hospital Tuebingen |
2013-10 | PHASE3 |
| NCT02091856 | TERMINATED | Mild - Major Depression |
West University of Timisoara |
2014-03 | |
| NCT02431598 | COMPLETED | Transient Severe Arterial Phase Motion |
Duke University |
2015-06 | PHASE4 |
| NCT02433236 | WITHDRAWN | IGA Nephropathy |
Rigel Pharmaceuticals |
2015-09 | PHASE2 |
| NCT03043521 | COMPLETED | Healthy |
HK inno.N Corporation |
2015-05-13 | PHASE1 |
| NCT02084628 | TERMINATED | Magnetic Resonance Imaging |
Bayer |
2015-02 | PHASE3 |
| NCT02243215 | COMPLETED | Off-site Training in Laparoscopy |
Zealand University Hospital |
2014-09 | |
| NCT00450801 | COMPLETED | Lymphoma |
University of Miami |
2004-04 | PHASE2 |
| NCT02145078 | TERMINATED | Recurrent Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2014-06 | |
| NCT02253186 | COMPLETED | Lymphedema |
Thuasne |
2014-09 | |
| NCT00539591 | ACTIVE_NOT_RECRUITING | Malignant Melanoma |
St. Jude Children's Research Hospital |
2008-05-09 | PHASE2 |
| NCT02105454 | COMPLETED | Hepatitis C Virus |
Merck Sharp & Dohme LLC |
2014-05-23 | PHASE2 |
| NCT02023112 | COMPLETED | Hepatitis C Virus |
AbbVie |
2014-01 | PHASE3 |
| NCT01928160 | WITHDRAWN | Recurrent Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer |
Vanderbilt-Ingram Cancer Center |
2014-06 | PHASE2 |
| NCT01681992 | COMPLETED | Measles; Mumps; Rubella; Measles-Mumps-Rubella Vaccine |
GlaxoSmithKline |
2012-10-10 | PHASE3 |
| NCT00096161 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Graft Versus Host Disease; Hodgkin Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2003-05 | PHASE2 |
| NCT01450384 | COMPLETED | Unspecified Adult Solid Tumor |
Virginia Commonwealth University |
2011-10 | PHASE1 |
| NCT01242514 | TERMINATED | Rheumatoid Arthritis |
AstraZeneca |
2011-01 | PHASE3 |
| NCT01001910 | COMPLETED | Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma |
Albert Einstein College of Medicine |
2008-07 | PHASE2 |
| NCT01748747 | COMPLETED | Recurrent Melanoma; Stage IIA Melanoma; Stage IIB Melanoma; Stage IIC Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma |
Mayo Clinic |
2012-10 | EARLY_PHASE1 |
| NCT02578602 | COMPLETED | Adult Hepatocellular Carcinoma; Advanced Adult Hepatocellular Carcinoma; BCLC Stage 0 Adult Hepatocellular Carcinoma; BCLC Stage A Adult Hepatocellular Carcinoma; BCLC Stage B Adult Hepatocellular Carcinoma; BCLC Stage C Adult Hepatocellular Carcinoma; BCLC Stage D Adult Hepatocellular Carcinoma; Localized Non-Resectable Adult Liver Carcinoma; Localized Resectable Adult Liver Carcinoma |
University of Southern California |
2010-10 | PHASE1 |
| NCT02583464 | COMPLETED | Acquired Immunodeficiency Syndrome |
Laboratorio Elea Phoenix S.A. |
2014-09 | PHASE1 |
| NCT02178254 | COMPLETED | Pseudomonas Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-08 | PHASE1 |
| NCT02099409 | COMPLETED | Type 1 Diabetes Mellitus |
Centre Hospitalier du Luxembourg |
2014-01 | |
| NCT02362178 | COMPLETED | Liver Cirrhosis; Coagulation Disorder |
University of Modena and Reggio Emilia |
2011-02 | PHASE2 |
| NCT00691301 | COMPLETED | Cervical Cancer |
Gynecologic Oncology Group |
2008-09 | PHASE2 |
| NCT01258439 | COMPLETED | HIV; Cardiovascular Disease |
St Vincent's Hospital, Sydney |
2010-11 | PHASE4 |
| NCT02028936 | COMPLETED | Healthy Subjects |
Centre Hospitalier Universitaire Dijon |
2013-10-24 | |
| NCT01533272 | COMPLETED | HIV Infection |
Hospital Clinic of Barcelona |
2012-02 | PHASE4 |
| NCT01672983 | COMPLETED | Chronic Hepatitis C Infection |
AbbVie (prior sponsor, Abbott) |
2012-07 | PHASE2 |
| NCT01440335 | COMPLETED | Congestive Heart Failure |
National Institute on Aging (NIA) |
2011-07-10 | PHASE1 |
| NCT01088906 | TERMINATED | Carcinoma, Non Small Cell Lung |
Spanish Lung Cancer Group |
2010-01 | PHASE2 |
| NCT01619462 | UNKNOWN | Pneumonia; Meningitis; Bacteraemia; Sepsis; Otitis Media |
Papua New Guinea Institute of Medical Research |
2011-11 | PHASE3 |
| NCT02065401 | WITHDRAWN | Healthy |
Shire |
2014-02-28 | PHASE1 |
| NCT01871532 | TERMINATED | Infertility; Monofollicular Development |
Merck KGaA, Darmstadt, Germany |
2013-07 | PHASE4 |
| NCT01497197 | TERMINATED | Infertility; Fertility; Follicle Stimulating Hormone Deficiency |
Merck KGaA, Darmstadt, Germany |
2012-05 | PHASE3 |
| NCT01502982 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Nordic Lymphoma Group |
2004-11 | PHASE2 |
| NCT01783314 | UNKNOWN | Hepatic Fibrosis |
Weill Medical College of Cornell University |
2010-12 | PHASE4 |
| NCT01953419 | COMPLETED | Gastric Cancer |
Sun Yat-sen University |
2010-09 | PHASE2 |
| NCT00520845 | TERMINATED | Lung Cancer |
Vanderbilt-Ingram Cancer Center |
2007-10 | PHASE2 |
| NCT01905540 | COMPLETED | Healthy |
Shire |
2013-08-05 | PHASE1 |
| NCT01469767 | COMPLETED | Atopic Dermatitis |
Wake Forest University |
2012-02-01 | PHASE2 |
| NCT00805467 | TERMINATED | Rheumatoid Arthritis |
AstraZeneca |
2008-08 | PHASE2 |
| NCT01610882 | COMPLETED | Acute Post-operative Pain |
University of British Columbia |
2012-05 | |
| NCT00908596 | COMPLETED | Contrast Media |
Bayer |
2009-05 | PHASE4 |
| NCT01393756 | COMPLETED | Follicular Lymphoma |
The Lymphoma Academic Research Organisation |
2010-12 | PHASE2 |
| NCT00410904 | COMPLETED | Recurrent Non-small Cell Lung Cancer |
National Cancer Institute (NCI) |
2006-10 | PHASE2 |
| NCT02092961 | TERMINATED | Rheumatoid Arthritis |
AstraZeneca |
2011-02 | PHASE2 |
| NCT02106130 | COMPLETED | Healthy |
IlDong Pharmaceutical Co Ltd |
2013-05 | PHASE1 |
| NCT00973804 | TERMINATED | Leukemia; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; MDS; Multiple Myeloma |
National Cancer Institute (NCI) |
2009-08-25 | PHASE1 |
| NCT01227512 | TERMINATED | Hyponatremia; Dilutional Hyponatremia; Inappropriate ADH Syndrome |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2010-10 | PHASE3 |
| NCT00617591 | COMPLETED | Multiple Myeloma |
H. Lee Moffitt Cancer Center and Research Institute |
2008-01 | PHASE2 |
| NCT00660816 | COMPLETED | Lung Cancer |
Case Comprehensive Cancer Center |
2008-01 | PHASE2 |
| NCT01662102 | TERMINATED | Follicular Lymphoma |
Spectrum Pharmaceuticals, Inc |
2012-12-11 | PHASE3 |
| NCT00438204 | TERMINATED | Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2006-05 | PHASE2 |
| NCT01348243 | COMPLETED | Postmenopausal Osteoporosis |
Chiesi Farmaceutici S.p.A. |
2011-10 | PHASE3 |
| NCT01197534 | COMPLETED | Rheumatoid Arthritis |
AstraZeneca |
2010-09 | PHASE3 |
| NCT01197755 | COMPLETED | Rheumatoid Arthritis |
AstraZeneca |
2010-09 | PHASE3 |
| NCT00911183 | COMPLETED | Lymphoma |
Institut Bergonié |
2008-12-02 | PHASE2 |
| NCT01013480 | TERMINATED | Fragile X Syndrome |
Seaside Therapeutics, Inc. |
2009-11 | PHASE2 |
| NCT01197521 | COMPLETED | Rheumatoid Arthritis |
AstraZeneca |
2010-09 | PHASE3 |
| NCT01264770 | TERMINATED | Rheumatoid Arthritis |
AstraZeneca |
2011-01 | PHASE2 |
| NCT02963103 | TERMINATED | Kidney Transplantation |
Astellas Pharma Korea, Inc. |
2010-05 | PHASE4 |
| NCT00301808 | COMPLETED | Lung Cancer |
Barbara Ann Karmanos Cancer Institute |
2005-11 | PHASE2 |
| NCT01513122 | COMPLETED | HIV |
Kirby Institute |
2010-02 | PHASE4 |
| NCT01613209 | COMPLETED | Hypertension |
Institut für Pharmakologie und Präventive Medizin |
2011-12 | PHASE3 |
| NCT01015859 | COMPLETED | Patients With Pacemaker With Conduction Problems |
Montreal Heart Institute |
2006-06 | PHASE4 |
| NCT00605098 | COMPLETED | HIV Infections; Pregnancy |
Oswaldo Cruz Foundation |
2008-02 | PHASE4 |
| NCT00925756 | COMPLETED | HIV Infections |
University of California, San Diego |
2008-10-20 | PHASE4 |
| NCT00848016 | COMPLETED | Recurrent Adrenocortical Carcinoma; Stage III Adrenocortical Carcinoma; Stage IV Adrenocortical Carcinoma |
National Cancer Institute (NCI) |
2009-02 | PHASE2 |
| NCT01181999 | UNKNOWN | Lymphoma, Large B-cell, Diffuse |
Chonnam National University Hospital |
2010-08 | PHASE2 |
| NCT01496937 | COMPLETED | Healthy |
Lakefront Biotherapeutics NV |
2011-12 | PHASE1 |
| NCT00702299 | COMPLETED | Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer |
University of Arizona |
2007-09 | PHASE1 |
| NCT00967837 | TERMINATED | Wound Healing; Diabetes |
Florida Atlantic University |
2006-01 | PHASE2; PHASE3 |
| NCT00698815 | COMPLETED | Recurrent Non-Small Cell Lung Carcinoma; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IV Non-Small Cell Lung Cancer AJCC v7 |
National Cancer Institute (NCI) |
2008-04-15 | PHASE2 |
| NCT01338792 | COMPLETED | Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer |
University of Southern California |
2006-06 | PHASE2 |
| NCT00738881 | TERMINATED | Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2008-10 | PHASE3 |
| NCT01007006 | WITHDRAWN | Traumatic Brain Injury; Posttraumatic Stress Disorders; Trauma; Combat Disorders; Pain |
University of Illinois at Chicago |
2010-12 | |
| NCT00863512 | TERMINATED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2009-03 | PHASE3 |
| NCT01106586 | COMPLETED | HIV; HIV Infections |
Gilead Sciences |
2010-04 | PHASE3 |
| NCT01308541 | COMPLETED | Monitored Anesthesia Care |
Eisai Inc. |
2011-01 | PHASE1 |
| NCT01221792 | UNKNOWN | Post-Traumatic Stress Disorder |
Columbia Northwest Pharmaceuticals |
2010-10 | PHASE2 |
| NCT01127438 | COMPLETED | Sedation |
Eisai Inc. |
2010-04 | PHASE4 |
| NCT01222455 | COMPLETED | Hepatic Impairment; Healthy Volunteers; Pharmacokinetics; Amount of R406 in Blood |
AstraZeneca |
2010-10 | PHASE1 |
| NCT01167868 | COMPLETED | Healthy |
AstraZeneca |
2010-07 | PHASE1 |
| NCT02007915 | TERMINATED | Femoral Head Avascular Necrosis |
The Hospital for Sick Children |
2009-07 | |
| NCT01105390 | WITHDRAWN | Advanced Malignant Mesothelioma; Epithelial Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma |
National Cancer Institute (NCI) |
2010-04 | PHASE2 |
| NCT00541073 | COMPLETED | Malignant Mesothelioma |
Centre Oscar Lambret |
2007-06 | PHASE2 |
| NCT00248495 | COMPLETED | Lung Cancer |
Roswell Park Cancer Institute |
2005-06-08 | PHASE2 |
| NCT01195103 | TERMINATED | Procedural Sedation; Regional Anesthesia Block; Orthopedic Surgery |
Mayo Clinic |
2011-02 | PHASE4 |
| NCT00798603 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2008-12 | PHASE2 |
| NCT00088881 | TERMINATED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2004-12 | PHASE2 |
| NCT00335322 | COMPLETED | Human Immunodeficiency Virus (HIV) |
Kirby Institute |
2007-02 | PHASE4 |
| NCT00875563 | COMPLETED | Abdominal Aortic Aneurysms; Aorto-iliac Aneurysms; Juxtarenal Aneurysms |
Cook Group Incorporated |
2005-01 | |
| NCT01260142 | COMPLETED | Anesthesia |
Eisai Inc. |
2010-11 | PHASE4 |
| NCT00389207 | COMPLETED | HIV Infections |
Boehringer Ingelheim |
2006-10 | PHASE3 |
| NCT00360685 | COMPLETED | Mucositis; Graft-versus-host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2005-09 | |
| NCT00627055 | COMPLETED | HIV Infections |
The HIV Netherlands Australia Thailand Research Collaboration |
2008-05 | PHASE4 |
| NCT01197781 | COMPLETED | Drug Drug Interactions; Healthy Volunteers |
AstraZeneca |
2010-09 | PHASE1 |
| NCT00333099 | COMPLETED | Malnutrition; Esophageal Cancer; Head and Neck Cancer |
University Hospital, Clermont-Ferrand |
2006-05 | PHASE4 |
| NCT00221117 | COMPLETED | Spinal Cord Injuries |
Toronto Rehabilitation Institute |
2005-08 | |
| NCT00919906 | COMPLETED | Asperger's Syndrome; Dyslexia; Cerebral Palsy; Attention Deficit Disorder; ADHD; Traumatic Brain Injury; Stroke |
Obslap Research LLC |
2009-04 | PHASE1; PHASE2 |
| NCT01271569 | COMPLETED | Drug Safety |
West China Hospital |
2010-03 | PHASE1 |
| NCT00703638 | COMPLETED | Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Lung Cancer; Mesothelioma; Pancreatic Cancer; Prostate Cancer; Sarcoma |
Masonic Cancer Center, University of Minnesota |
2008-05 | PHASE1 |
| NCT00492440 | TERMINATED | Kidney Cancer; Melanoma (Skin) |
Cytheris SA |
2007-05 | PHASE1 |
| NCT00454194 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2007-09 | PHASE2 |
| NCT00437476 | UNKNOWN | HIV Infections; Hepatitis C |
IRCCS San Raffaele |
2007-02 | PHASE3 |
| NCT00437684 | UNKNOWN | HIV Infections; Hepatitis C |
IRCCS San Raffaele |
2007-02 | PHASE3 |
| NCT00490841 | COMPLETED | Renal Artery Obstruction; Hypertension, Renal |
Abbott Medical Devices |
2007-08 | |
| NCT00521053 | COMPLETED | Melanoma |
Provectus Pharmaceuticals |
2007-09 | PHASE2 |
| NCT00798096 | COMPLETED | T Cell Lymphoma |
Rigel Pharmaceuticals |
2009-03 | PHASE2 |
| NCT00706342 | COMPLETED | Purpura, Thrombocytopenic, Idiopathic |
Rigel Pharmaceuticals |
2007-01 | PHASE2 |
| NCT00227539 | COMPLETED | Lung Cancer |
University of Washington |
2005-07 | PHASE2 |
| NCT00675857 | COMPLETED | Diabetes Mellitus, Type 2; Metabolic Syndrome X |
Bellus Health Inc. - a GSK company |
2008-04 | PHASE2 |
| NCT00159224 | COMPLETED | HIV Infections |
Fundación Huésped |
2005-04 | PHASE4 |
| NCT00888940 | COMPLETED | Bloodloss; Surgical Procedures, Operative |
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) |
2009-06 | PHASE2 |
| NCT02183636 | COMPLETED | Healthy |
Boehringer Ingelheim |
2009-08 | PHASE1 |
| NCT01049685 | UNKNOWN | HIV Infections |
UPECLIN HC FM Botucatu Unesp |
2006-08 | PHASE4 |
| NCT00752999 | WITHDRAWN | Systemic Lupus Erythematosus |
Rigel Pharmaceuticals |
2008-11 | PHASE2 |
| NCT00418925 | UNKNOWN | Cervical Dystonia |
University Health Network, Toronto |
2006-09 | PHASE2 |
| NCT00436280 | COMPLETED | Lymphoma, Large Cell, Diffuse |
Eli Lilly and Company |
2007-02 | PHASE2 |
| NCT00549835 | WITHDRAWN | Mucositis; Pain; Leukemia |
Johns Hopkins University |
2007-08 | |
| NCT00101283 | COMPLETED | Mesothelioma |
Eastern Cooperative Oncology Group |
2006-02-23 | PHASE2 |
| NCT00645879 | COMPLETED | Propionic Acidemia |
Nicola Longo |
2008-07 | PHASE1 |
| NCT00039741 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2002-08 | PHASE2; PHASE3 |
| NCT00364819 | COMPLETED | Primary Biliary Cirrhosis |
University of California, Davis |
2007-01 | PHASE1; PHASE2 |
| NCT00665925 | COMPLETED | Rheumatoid Arthritis |
Rigel Pharmaceuticals |
2008-05 | PHASE2 |
| NCT00665626 | COMPLETED | Rheumatoid Arthritis |
Rigel Pharmaceuticals |
2008-05 | PHASE2 |
| NCT00124605 | COMPLETED | Refractory Multiple Myeloma; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2005-04 | PHASE1 |
| NCT00503997 | COMPLETED | Head and Neck Cancer |
Vanderbilt-Ingram Cancer Center |
2006-12 | PHASE2 |
| NCT00855114 | WITHDRAWN | Breast Cancer |
Masonic Cancer Center, University of Minnesota |
2008-07 | PHASE2 |
| NCT00573690 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
UNC Lineberger Comprehensive Cancer Center |
2007-09 | PHASE1 |
| NCT00923481 | COMPLETED | Head and Neck Neoplasms; Pheochromocytoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell |
National Cancer Institute (NCI) |
2009-04 | PHASE2 |
| NCT00204542 | COMPLETED | Photosensitivity Disorders |
University Hospital Tuebingen |
2005-06 | PHASE4 |
| NCT00117962 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2005-09 | PHASE2 |
| NCT00553514 | TERMINATED | Ovulation Induction |
Merck KGaA, Darmstadt, Germany |
2007-12 | PHASE2 |
| NCT00774800 | COMPLETED | Type 1 Diabetes Mellitus |
Halozyme Therapeutics |
2008-10 | PHASE2 |
| NCT00740649 | COMPLETED | Healthy Subjects |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-10 | PHASE1 |
| NCT00271960 | COMPLETED | Sexually Transmitted Diseases; HIV Infections |
Yale University |
2001-04 | PHASE3 |
| NCT00280748 | TERMINATED | Lung Cancer; Metastatic Cancer |
UNC Lineberger Comprehensive Cancer Center |
2005-05 | PHASE2 |
| NCT00320073 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
UNC Lineberger Comprehensive Cancer Center |
2006-08 | PHASE1 |
| NCT00777348 | COMPLETED | Asthma, Exercise-Induced |
MEDA Pharma GmbH & Co. KG |
2007-11 | PHASE2 |
| NCT00440271 | TERMINATED | HIV Infections |
Boehringer Ingelheim |
2007-02 | PHASE3 |
| NCT00555646 | TERMINATED | Plaque Psoriasis |
Provectus Pharmaceuticals |
2007-11 | PHASE2 |
| NCT00531986 | TERMINATED | HIV Infections |
Cantonal Hospital of St. Gallen |
2007-01 | PHASE4 |
| NCT00454337 | COMPLETED | HIV Infections |
French National Agency for Research on AIDS and Viral Hepatitis |
2007-05 | PHASE3 |
| NCT00526188 | COMPLETED | Known or Suspected Focal Liver Lesions |
Bayer |
2007-08 | PHASE3 |
| NCT00808704 | COMPLETED | Hypoxic-Ischemic Encephalopathy |
Zhengzhou University |
2003-08 | PHASE1; PHASE2 |
| NCT00590941 | COMPLETED | Lymphoma; Diffuse Large Cell |
Washington University School of Medicine |
2005-02 | |
| NCT00389688 | TERMINATED | Lung Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-08 | PHASE2 |
| NCT00237354 | COMPLETED | Breast Cancer |
Provectus Pharmaceuticals |
2005-10 | PHASE1 |
| NCT00310050 | TERMINATED | Pancreatic Cancer |
Wake Forest University Health Sciences |
2005-10 | PHASE1 |
| NCT00486031 | COMPLETED | Inflammatory Bowel Disease; Ulcerative Colitis |
Bausch Health Americas, Inc. |
2006-10 | PHASE3 |
| NCT00676156 | COMPLETED | Multiple Sclerosis |
Oregon Health and Science University |
2005-12 | PHASE1 |
| NCT00407550 | COMPLETED | Lung Cancer |
Mayo Clinic |
2006-11 | PHASE2 |
| NCT01223079 | COMPLETED | Outcome During r-hFSH Stimulation; Outcome During r-hFSH and r-hLH Stimulation |
Reproductive Medicine Associates of New Jersey |
2005-12 | |
| NCT00227565 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2006-02 | PHASE2 |
| NCT00003573 | COMPLETED | Brain Tumors; Central Nervous System Tumors |
Children's Oncology Group |
1998-11 | PHASE2 |
| NCT00387322 | COMPLETED | Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
University of California, Davis |
2005-03 | PHASE1; PHASE2 |
| NCT00250679 | COMPLETED | Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema |
Sumitomo Pharma America, Inc. |
2005-10 | PHASE3 |
| NCT02229760 | TERMINATED | HIV Infections |
Boehringer Ingelheim |
2006-08 | PHASE1; PHASE2 |
| NCT00053209 | COMPLETED | Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer |
Eastern Cooperative Oncology Group |
2004-08-10 | PHASE2 |
| NCT00408616 | COMPLETED | Allergy |
ALK-Abelló A/S |
2006-11 | PHASE3 |
| NCT00289783 | COMPLETED | Haemophilus Influenzae Type b; Neisseria Meningitidis |
GlaxoSmithKline |
2006-02-22 | PHASE3 |
| NCT00227630 | COMPLETED | Malignant Mesothelioma |
European Organisation for Research and Treatment of Cancer - EORTC |
2005-07 | PHASE2 |
| NCT00087100 | COMPLETED | Endometrial Cancer |
Gynecologic Oncology Group |
2006-05 | PHASE2 |
| NCT00096187 | TERMINATED | Gestational Trophoblastic Tumor |
Gynecologic Oncology Group |
2005-07 | PHASE2 |
| NCT00408174 | COMPLETED | Inflammatory Bowel Disease; Ulcerative Colitis |
Bausch Health Americas, Inc. |
2006-05 | PHASE3 |
| NCT00470405 | COMPLETED | Lymphoma; Solid Tumor |
Vanderbilt-Ingram Cancer Center |
2004-05 | PHASE1 |
| NCT00444860 | COMPLETED | Varicella Virus Infection |
Merck Sharp & Dohme LLC |
2007-03 | PHASE3 |
| NCT00107419 | COMPLETED | Sarcoma |
SWOG Cancer Research Network |
2005-09 | PHASE2 |
| NCT00268489 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2006-05 | PHASE2 |
| NCT01136525 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2007-02 | PHASE1 |
| NCT00269438 | COMPLETED | Ulcerative Colitis |
Bausch Health Americas, Inc. |
2005-12 | PHASE3 |
| NCT00060242 | COMPLETED | Head and Neck Cancer |
Case Comprehensive Cancer Center |
2003-02 | PHASE2 |
| NCT00059865 | COMPLETED | Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer |
Alliance for Clinical Trials in Oncology |
2004-01 | PHASE1; PHASE2 |
| NCT00077103 | TERMINATED | Head and Neck Cancer |
Case Comprehensive Cancer Center |
2003-11 | PHASE1; PHASE2 |
| NCT00649480 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2007-01 | PHASE1 |
| NCT00087087 | COMPLETED | Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
2004-07 | PHASE2 |
| NCT00389805 | COMPLETED | Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
University of California, Davis |
2005-03 | PHASE1; PHASE2 |
| NCT00087113 | COMPLETED | Cervical Cancer |
Gynecologic Oncology Group |
2004-08 | PHASE2 |
| NCT00445107 | COMPLETED | Asthma |
Organon and Co |
2005-11-01 | PHASE3 |
| NCT00070473 | COMPLETED | Unspecified Childhood Solid Tumor, Protocol Specific |
Children's Oncology Group |
2003-10 | PHASE1 |
| NCT00033332 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
National Cancer Institute (NCI) |
2002-04 | PHASE3 |
| NCT00194402 | COMPLETED | Dyslipidemia |
University of Washington |
2003-08 | PHASE4 |
| NCT00170547 | COMPLETED | Influenza |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-09 | PHASE2 |
| NCT00618202 | COMPLETED | Ulcerative Colitis |
Roxane Laboratories |
2005-05 | |
| NCT00209586 | TERMINATED | Flexible Bronchoscopy |
Eisai Inc. |
2004-09 | PHASE3 |
| NCT00064415 | COMPLETED | Chronic Obstructive Pulmonary Disease; Chronic Bronchitis; Emphysema |
Sumitomo Pharma America, Inc. |
2002-06 | PHASE3 |
| NCT00648531 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2004-05 | PHASE1 |
| NCT00927277 | COMPLETED | Pain |
Erchonia Corporation |
2003-03 | |
| NCT00006007 | COMPLETED | Breast Cancer |
Alliance for Clinical Trials in Oncology |
2000-12 | PHASE2 |
| NCT00657852 | COMPLETED | Bone Disease, Metabolic |
Hospital Clinic of Barcelona |
2000-12 | PHASE4 |
| NCT00022646 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2001-08 | PHASE2 |
| NCT00003706 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
The University of Texas Health Science Center at San Antonio |
1998-04 | PHASE1 |
| NCT00003232 | COMPLETED | Pain; Prostate Cancer; Quality of Life |
NCIC Clinical Trials Group |
1997-11-24 | PHASE3 |
| NCT00006037 | TERMINATED | Colorectal Cancer |
University of Southern California |
1999-11 | PHASE2 |
| NCT02238314 | COMPLETED | HIV Infections |
Boehringer Ingelheim |
1999-01 | PHASE2 |
| NCT00003768 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Case Comprehensive Cancer Center |
1998-09 | PHASE1 |
| NCT00005636 | COMPLETED | Malignant Mesothelioma |
Memorial Sloan Kettering Cancer Center |
1999-11 | PHASE3 |
| NCT00003773 | COMPLETED | Ovarian Cancer |
University of Southern California |
1999-02 | PHASE1 |
| NCT01380496 | COMPLETED | To Determine Bioequivalence Under Fed Conditions |
Par Pharmaceutical, Inc. |
1999-11 | PHASE1 |
| NCT01066052 | COMPLETED | Turner's Syndrome |
Merck KGaA, Darmstadt, Germany |
1992-02-29 | PHASE4 |
| NCT00744445 | COMPLETED | Hemodialysis; Chronic Renal Failure; Anemia |
Sunnybrook Health Sciences Centre |
1993-10 | PHASE2 |
| NCT00002396 | UNKNOWN | HIV Infections |
Gilead Sciences |
PHASE1 | |
| NCT00282594 | COMPLETED | Sepsis; Respiratory Failure; Renal Failure; Surgical Site Infection |
Genesys |
2003-07 | |
| NCT00327392 | COMPLETED | Procedural Sedation |
Eisai Inc. |
2006-05 | PHASE2; PHASE3 |
| NCT00989690 | UNKNOWN | Lung Cancer |
Istituto Scientifico H. San Raffaele |
2008-02 | PHASE3 |
| NCT00306722 | COMPLETED | Bronchoscopy; Anesthesia |
Eisai Inc. |
2006-04 | PHASE3 |
| NCT01101412 | WITHDRAWN | Chronic Myeloproliferative Disorders; Infection; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Adult Solid Tumor, Protocol Specific |
M.D. Anderson Cancer Center |
PHASE1; PHASE2 | |
| NCT00209573 | COMPLETED | Colonoscopy; Colon Polyps |
Eisai Inc. |
2004-09 | PHASE3 |
| NCT00209534 | COMPLETED | Colonoscopy; Colon Polyps |
Eisai Inc. |
2003-01 | PHASE2 |
| NCT00269958 | COMPLETED | Anemia |
Janssen-Ortho Inc., Canada |
PHASE2 | |
| NCT00002003 | COMPLETED | Lymphoma, Non-Hodgkin; HIV Infections |
Lederle Laboratories |
PHASE2 | |
| NCT00125398 | COMPLETED | Postoperative Sedation; Intubation; Respiration, Artificial |
Eisai Inc. |
2005-07 | PHASE2 |
| NCT00567957 | UNKNOWN | Pre-Eclampsia; Hypertension, Pregnancy-Induced; Pregnancy Complications |
Istanbul University |
2008-02 | PHASE4 |
| NCT00261599 | COMPLETED | Conscious Sedation |
Eisai Inc. |
2006-03 | PHASE3 |
| NCT00125424 | COMPLETED | Colonoscopy; Colonic Polyps |
Eisai Inc. |
2005-07 | PHASE2; PHASE3 |
| NCT00227409 | COMPLETED | Urologic Disease |
Chang Gung Memorial Hospital |
2001-11 | |
| NCT00219843 | COMPLETED | Melanoma |
Provectus Pharmaceuticals |
2005-08 | PHASE1 |
| NCT00536393 | COMPLETED | Lymphoma |
French Innovative Leukemia Organisation |
2000-10 | PHASE2; PHASE3 |
| NCT00270010 | COMPLETED | Anemia; Acquired Immunodeficiency Syndrome |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
PHASE2 | |
| NCT00368758 | UNKNOWN | Irritable Bowel Syndrome |
Royal Veterinary and Agricultural University, Denmark |
2006-08 | |
| NCT00209547 | COMPLETED | Angioplasty; Coronary Catheterization |
Eisai Inc. |
2004-02 | PHASE3 |
| NCT00003711 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
San Antonio Cancer Institute |
1997-09 | PHASE1 |
| NCT00002071 | COMPLETED | HIV Infections; Cytopenias |
Ortho Pharmaceuticals |
||
| NCT00004906 | COMPLETED | Breast Cancer |
Hackensack Meridian Health |
1999-10 | PHASE2 |
| NCT00209599 | TERMINATED | Colonoscopy; Colon Polyps |
Eisai Inc. |
2005-02 | PHASE2 |
| NCT00002303 | COMPLETED | HIV Infections; Cytopenias |
Ortho Pharmaceuticals |
||
| NCT00209560 | TERMINATED | Arthroscopy; Bunionectomy; Osteotomy; Carpal Tunnel |
Eisai Inc. |
2004-10 | PHASE3 |
| NCT00003698 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
University of Glasgow |
1998-07 | PHASE1 |
| NCT00293878 | COMPLETED | Hypercholesterolemia |
Forbes Medi-Tech |
2005-11 | PHASE2 |
| NCT00017303 | UNKNOWN | Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Cytran |
2001-01 | PHASE2 |
| NCT00196144 | COMPLETED | Atrial Fibrillation |
Deutsches Herzzentrum Muenchen |
2002-07 | PHASE4 |
| NCT00333853 | COMPLETED | Diabetes |
LifeScan |
2003-08 | |
| NCT00269984 | COMPLETED | Anemia |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-06-11)
Check the
Disodium (R)-2-Hydroxyglutarate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Disodium (R)-2-Hydroxyglutarate Mechanism of Action: ATP Synthase Inhibition in Cancer Cells Research
- Disodium (R)-2-Hydroxyglutarate: Selectivity & Specificity
- Disodium (R)-2-Hydroxyglutarate Working Concentration | Cell Culture | Treatment
- Disodium (R)-2-Hydroxyglutarate Solubility in DMSO
- Disodium (R)-2-Hydroxyglutarate Stock Solution
- Disodium (R)-2-Hydroxyglutarate Storage
- Disodium (R)-2-Hydroxyglutarate Stability
- Disodium (R)-2-Hydroxyglutarate Combination Database
- Disodium (R)-2-Hydroxyglutarate Molecular Weight
- Disodium (R)-2-Hydroxyglutarate SMILES
- Disodium (R)-2-Hydroxyglutarate CAS Number
- Disodium (R)-2-Hydroxyglutarate Chemical Structure (2D and 3D)
- Disodium (R)-2-Hydroxyglutarate IC50 for Cell-based and Cell-free Assays
- Disodium (R)-2-Hydroxyglutarate Sigma (16859)? Try a better option.
- Disodium (R)-2-Hydroxyglutarate APExBIO (B6018)? Try a better option.
- Disodium (R)-2-Hydroxyglutarate Cayman (11605)? Try a better option.
- Disodium (R)-2-Hydroxyglutarate MedChemExpress (HY-100542)? Try a better option.
- Disodium (R)-2-Hydroxyglutarate SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.